Stem (STMH) 10-K/A 23 Jan 23 2022 FY Annual report (amended) Financial data

Cover

Cover - USD ($)	12 Months Ended
	Sep. 30, 2022	Jan. 12, 2023	Mar. 31, 2022
Cover [Abstract]
Document Type	10-K/A
Amendment Flag	true
Amendment Description	The purpose of this amendment on Form 10-K/A to Stem Holdings, Inc.'s Annual Report on Form 10-K for the year ended September 30, 2022, filed with the Securities and Exchange Commission on January 13, 2023 is solely to furnish the Inline eXtensible Business Reporting Language (iXBRL) data under Exhibit 101 and 104 to the Form 10-K in accordance with Rule 405 of Regulation S-T.
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2022
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--09-30
Entity File Number	000-55751
Entity Registrant Name	STEM HOLDINGS, INC.
Entity Central Index Key	0001697834
Entity Tax Identification Number	61-1794883
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	2201 NW Corporate Blvd.
Entity Address, Address Line Two	Suite 205
Entity Address, City or Town	Boca Raton
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33431
City Area Code	(561)
Local Phone Number	948-5410
Title of 12(b) Security	Common Stock par value $0.001
Trading Symbol	STMH
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	Yes
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 14,404,213
Entity Common Stock, Shares Outstanding		238,504,032
Documents Incorporated by Reference [Text Block]	NONE
Auditor Name	LJ Soldinger Associates, LLC
Auditor Location	Deer Park, IL
Auditor Firm ID	318

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 30, 2021
Current assets
Cash and cash equivalents	$ 1,524	$ 5,464
Accounts receivable, net of allowance for doubtful accounts	313	260
Note receivable		430
Inventory	2,675	3,126
Prepaid expenses and other current assets	929	2,187
Assets held for sale		9,324
Total current assets	5,441	20,791
Property and equipment, net	9,089	12,598
Investment in equity method investees		1,008
Investments in affiliates		230
Deposits and other assets	13	13
Right of use asset	6,874	4,235
Intangible assets, net	8,014	10,856
Goodwill	1,522	7,429
Due from related party	28	28
Total assets	30,981	57,188
Current liabilities
Accounts payable and accrued expenses	2,310	2,547
Convertible notes, net	1,477	2,940
Convertible notes, net related party		223
Current maturities of long-term debt	1,000
Short term notes and advances	451	650
Due to related party		1
Derivative liability	370
Lease liability	580	467
Warrant liability	55	2,277
Liabilities held for sale		6,801
Total current liabilities	6,243	15,906
Lease liability - long term	6,476	3,855
Finance liability		1,093
Long-term debt, mortgages	1,225	2,100
Total liabilities	13,944	22,954
Commitments and contingencies (Note 20)
Shareholders’ equity
Preferred stock
Common stock, $0.001 par value; 750,000,000 shares authorized; 227,013,967 and 230,738,620 shares issued, issuable and outstanding as of September 30, 2022 and September 30, 2021, respectively	227	230
Additional paid-in capital	148,450	148,249
Stock subscription receivable		(135)
Accumulated deficit	(133,118)	(115,750)
Total Stem Holdings stockholder’s equity	15,559	32,594
Noncontrolling interest	1,478	1,640
Total shareholders’ equity	17,037	34,234
Total liabilities and shareholders’ equity	30,981	57,188
Series A Preferred Stock [Member]
Shareholders’ equity
Preferred stock
Series B Preferred Stock [Member]
Shareholders’ equity
Preferred stock

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2022	Sep. 30, 2021
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	750,000,000	750,000,000
Common stock, shares issued	227,013,967	230,738,620
Common stock, shares issuable	227,013,967	230,738,620
Common stock, shares outstanding	227,013,967	230,738,620
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares outstanding	0	0
Series B Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares outstanding	0	0

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Revenues	$ 16,563	$ 20,937
Cost of goods sold	14,440	14,387
Gross Profit	2,123	6,550
Operating expenses:
Consulting fees	684	2,863
Professional fees	2,672	3,263
General and administration	11,125	11,802
Impairment expense – investments	795	2,235
Impairment expense – other intangible assets	1,968
Impairment expense – goodwill	5,907
Total operating expenses	23,151	20,163
Loss from operations	(21,028)	(13,613)
Other income (expenses), net
Interest expense	(650)	(1,953)
Change in fair value of derivative liability	(31)	577
Change in fair value of warrant liability	2,327	2,401
Foreign currency exchange gain (loss)	(4)	91
Other income	1,997	2,221
Gain on extinguishment of debt	803
Other loss	(30)
Total other income (expense)	4,412	3,337
Loss from continuing operations	(16,616)	(10,276)
Loss from equity method investees		(234)
Loss from discontinued operations, net of tax and gain on disposal of $831	(914)	(54,096)
Net loss	(17,530)	(64,606)
Net loss attributable to non-controlling interest	(162)	(242)
Net loss attributable to Stem Holdings	$ (17,368)	$ (64,364)
Basic and diluted loss from continuing operations, per share	$ (0.07)	$ (0.06)
Basic and diluted loss from discontinued operations, per share	(0.01)	(0.34)
Basic and diluted net loss, per share	$ (0.08)	$ (0.40)
Weighted-average shares outstanding
Basic	226,168,193	159,305,442
Diluted	226,168,193	159,305,442

Consolidated Statements of Op_2

Consolidated Statements of Operations (Parenthetical) $ in Thousands	12 Months Ended
	Sep. 30, 2022 USD ($)
Income Statement [Abstract]
Gain on disposal of discontinued operations	$ 831

Consolidated Statement of Chang

Consolidated Statement of Changes in Stockholders' Equity - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Subscription Receivable [Member]	Retained Earnings [Member]	Parent [Member]	Noncontrolling Interest [Member]	Total
Beginning balance, value at Sep. 30, 2020	$ 68	$ 76,310		$ (51,386)	$ 24,992	$ 1,840	$ 26,832
Beginning balance, shares at Sep. 30, 2020	68,258,745
Issuance of common stock in connection with consulting agreement	$ 5	2,027			2,032		2,032
Issuance of common stock in connection with consulting agreement, shares	4,790,070
Issuance of common stock in related to commission expense	$ 1	40			41		41
Issuance of common stock in related to commission expense, shares	90,909
Common stock issued for cash	$ 7	2,863			2,870		2,870
Common stock issued for cash, shares	6,833,069
Stock based compensation	$ 4	1,671			1,675		1,675
Stock based compensation, shares	3,914,509
Issuance of common stock in connection with convertible debt	$ 10	4,903			4,913		4,913
Issuance of common stock in connection with convertible debt, shares	9,480,259
Issuance of common stock in connection with deposit for an asset acquisition		2,582			2,582		2,582
Issuance of common stock in connection with deposit for an asset acquisition, shares	300,000
Cancellation of common stock related to convertible notes	$ (1)	1
Cancellation of common stock related to convertible notes, shares	(525,400)
Issuance of common stock related to interest expense	$ 1	426			427		427
Issuance of common stock related to rent and interest expense, shares	847,117
Issuance of subscription receivable		600			600		600
Cancellation of common stock related to investments	$ (1)	1
Cancellation of common stock related to investments, shares	(694,233)
Issuance of common stock related to settlement payment	$ 1	5,439			5,440		5,440
Issuance of common stock related to settlement payment, shares	500,000
Issuance of common stock related to Private Placement Memorandum, net	$ 5	4,892			4,897		4,897
Issuance of common stock related to Private Placement Memorandum, net, shares	5,322,136
Issuance of common stock related to Prospectus	$ 19	7,900			7,919		7,919
Issuance of common stock related to Prospectus, shares	19,276,340
Issuance of common stock related to cash purchase	$ 1	629			630		$ 630
Issuance of common stock related to cash purchase, shares	1,465,117						1,465,117
Issuance of common stock related to exercise of options		1			1		$ 1
Issuance of common stock related to exercise of options, shares	10,000
Issuance of warrants in connection with employment agreement		238			238		238
Issuance of options in connection with employment agreement		406			406		406
Recognition of non-controlling interest related to asset acquisition						42	42
Impairment of investment
Share exchange agreement adjustment
Cancellation of common stock in connection with Subscription Agreement
Cancellation of common stock in connection with Subscription Agreement, shares	(58,140)
Issuance of common stock in connection with asset acquisitions	$ 8				8		8
Issuance of common stock in connection with asset acquisitions, shares	8,209,178
Acquisition of Driven Deliveries, Inc. and adjustments	$ 102	37,320	(135)		37,287		$ 37,287
Acquisition of Driven Deliveries, Inc. and adjustments, shares	101,968,944						101,968,944
Net loss				(64,364)	(64,364)	(242)	$ (64,606)
Ending balance, value at Sep. 30, 2021	$ 230	148,249	(135)	(115,750)	32,594	1,640	34,234
Ending balance, shares at Sep. 30, 2021	229,988,620
Issuance of common stock in connection with consulting agreement		30			30		30
Issuance of common stock in connection with consulting agreement, shares	130,000
Common stock issued for cash	$ 3	282			285		285
Common stock issued for cash, shares	3,223,611
Stock based compensation	$ 3	310			313		313
Stock based compensation, shares	3,137,500
Issuance of common stock related to interest expense	$ 2	119			121		121
Issuance of common stock related to rent and interest expense, shares	1,751,186
Issuance of options in connection with employment agreement		454			454		454
Net loss				(17,368)	(17,368)	(162)	(17,530)
Common stock issued related to conversion of debt	$ 1	5			6		6
Common stock issued related to conversion of debt, shares	289,750
Common stock cancelled related to discontinued operations	$ (12)	(1,169)	135		(1,046)		(1,046)
Common stock cancelled related to discontinued operations, shares	(11,506,700)
Issuance of warrants in connection with consulting agreement		158			158		158
Issuance of warrants in connection with extension of debenture maturity		12			12		12
Ending balance, value at Sep. 30, 2022	$ 227	$ 148,450		$ (133,118)	$ 15,559	$ 1,478	$ 17,037
Ending balance, shares at Sep. 30, 2022	227,013,967

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 17,530	$ 64,606
Equity method investee loss		234
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	797	2,082
Issuance of common stock in connection with consulting agreements	263	2,270
Issuance of common stock related to rent and interest expense	264	427
Impairment of intangible assets	1,961
Impairment of investments	795
Impairment of goodwill	5,907
Depreciation and amortization	1,612	1,895
Amortization of intangible assets	881	345
Gain on extinguishment of debt	(803)
Amortization of debt discount	96	615
Impairment of note receivable		560
Gain on sale of equity method investments	(488)	(52)
Recognition of derivative liability		(577)
Change in fair value of warrant liability and derivative liability	(2,296)	(2,401)
Foreign currency adjustment	4	91
Gain on sale of property	(1,370)	(766)
Other		288
Changes in operating assets and liabilities:
Accounts receivable, net of allowance for doubtful accounts	(53)	294
Prepaid expenses and other current assets	2,367	(2,061)
Inventory	451	(907)
Accounts payable and accrued expenses	(238)	(1,106)
Net cash used in continuing operating activities	(7,380)	(9,279)
Net cash provided by (used in) discontinued operating activities	914
Net cash used in operating activities	(6,466)	(9,279)
Cash flows from investing activities
Purchase of property and equipment	(215)	(577)
Project costs		(179)
Cash received from sale of property	1,832
Cash received related to sale of equity method investment and note receivable	1,651	1,514
Issuance of note receivable		(560)
Investments	(82)
Related party payments
Net cash provided by continuing investing activities	3,186	198
Net cash provided by investing activities	3,186	198
Cash flows from financing activities
Proceeds from the issuance of common stock	285	15,746
Notes payable and advanced proceeds	252
Debt conversions		(100)
PPP and debt forgiveness		(1,031)
Repayments of notes payable	(1,197)	(2,199)
Net cash provided by (used in) financing activities from continuing operations	(660)	12,416
Net cash provided by financing activities	(660)	12,416
Net (decrease) increase in cash and cash equivalents	(3,940)	3,335
Cash and cash equivalents at the beginning of the period	5,464	2,129
Cash and cash equivalents at the end of the period	1,524	5,464
Supplemental disclosure of cash flow information:
Cash paid for interest	308	1,151
Cash paid for taxes
Supplemental disclosure of noncash activities:
Non-cash repayment of finance liability	1,092
Financed Insurance	449	598
Interest paid in the form of common stock	67	218
Issuance of common stock related to separation agreement		290
Acquisition of JV Retail 3 and JV Retail 4		1,323
Acquisition of Artifact		1,058
Conversion of debt and accrued interest to equity		4,913
Issuance of common stock for settlement		5,440
Refinancing of mortgage	$ 1,100	$ 1,100

Incorporation and Operations an

Incorporation and Operations and Going Concern	12 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Incorporation and Operations and Going Concern	1. Incorporation and Operations and Going Concern Stem Holdings, Inc. (“Stem” or the “Company”) is a Nevada corporation incorporated on June 7, 2016, and is a leading omnichannel, vertically-integrated cannabis branded products and technology company with state-of-the-art cultivation, processing, extraction, retail, distribution, and delivery-as-a-service (DaaS) operations throughout the United States. Stem’s family of award-winning brands includes TJ’s Gardens™, TravisxJames™, and Yerba Buena™ flower and extracts; Cannavore™ edible confections; and e-commerce delivery platforms provide direct-to consumer proprietary logistics and an omnichannel UX (user experience)/CX (customer experience). The Company purchases, improves, leases, operates, and invests in properties for use in the production, distribution and sales of cannabis and cannabis-infused products licensed under the laws of the states of Oregon, Nevada, and California. As of September, 30, 2022, Stem had ownership interests in 23 state issued cannabis licenses including nine (9) licenses for cannabis cultivation, three (3) licenses for cannabis processing, two (2) licenses for cannabis wholesale distribution, three (3) licenses for hemp production and (6) cannabis dispensary licenses. The Company has nine wholly-owned subsidiaries, including Stem Holdings Oregon, Inc., Stem Holdings IP, Inc., Opco, LLC, Stem Agri, Inc., Stem Holdings Oregon Acquisitions 1, Corp., Stem Holdings Oregon Acquisitions 2, Corp., Stem Holdings Oregon Acquisitions 3, Corp., Stem Holdings Oregon Acquisitions 4 Corp., 2336034 Alberta Ltd. Stem, through its subsidiaries, is currently in the process of seeking the acquisition of entities or to be acquired by entities directly in the production and sale of cannabis. Driven Deliveries, Inc., a former wholly-owned subsidiary, was sold during the quarter ended December 31, 2021 (see Note 3). The Company’s stock is publicly traded and is listed on the Canadian Securities Exchange under the symbol “STEM” and the OTCQB exchange under the symbol “STMH”. In June 2021, the Company’s shareholders approved a proposal to amend the Company’s Articles of Incorporation to increase the number of authorized common shares from 300,000,000 750,000,000 Going Concern On September 30, 2022, the Company had approximate balances of cash and cash equivalents of $ 1.5 802 133 These audited consolidated financial statements have been prepared on a going concern basis, which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business. The United States federal government regulates drugs in large part through the Controlled Substances Act or CSA. Marijuana, which refers to certain parts and derivatives of the cannabis plant, is classified as a Schedule I controlled substance. As a Schedule I controlled substance, the federal Drug Enforcement Agency, or DEA, considers marijuana to have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use of the drug under medical supervision. According to the U.S. federal government, cannabis having a concentration of tetrahydrocannabinol, or THC, greater than 0.3% is marijuana. Cannabis with a THC content below 0.3% is classified as hemp. The scheduling of marijuana as a Schedule I controlled substance is inconsistent with what we believe to be widely accepted medical uses for marijuana by physicians, researchers, customers, and others. Moreover, as of December 31, 2021, and despite the conflict with U.S. federal law, at least 36 states, the District of Columbia, the Commonwealth of the Northern Mariana Islands, Guam, Puerto Rico, and the U.S. Virgin Islands have legalized marijuana for medical use. Eighteen of those states and the District of Columbia, the Commonwealth of the Northern Mariana Islands, and Guam have legalized the adult use of cannabis for recreational purposes. In November 2020, voters in Arizona, Montana, New Jersey, and South Dakota voted by referendum to legalize marijuana for adult use, and voters in Mississippi and South Dakota voted to legalize marijuana for medical use, although South Dakota’s adult-use measure has been declared unconstitutional by the State Supreme Court. In 2021, the states of Connecticut, New Mexico, New York, and Virginia enacted laws legalizing the adult use of cannabis. Marijuana is largely regulated at the state level in the United States. State laws regulating marijuana conflict with the CSA, making marijuana use and possession federally illegal. Although certain states and territories of the United States authorize medical or adult-use marijuana production and distribution by licensed or registered entities, under United States federal law, the possession, use, cultivation, and transfer of marijuana and any related drug paraphernalia is illegal. Although our activities are compliant with the applicable state and local laws in those states where we maintain such licenses, strict compliance with state and local laws with respect to cannabis may neither absolve us of liability under United States federal law nor provide a defense to any federal criminal action that may be brought against us. In 2013, as more and more states began to legalize medical and/or adult-use marijuana, the federal government attempted to provide clarity on the incongruity between federal law and these state-legal regulatory frameworks. Until 2018, the federal government provided guidance to federal agencies and banking institutions through a series of DOJ memoranda. The most notable of this guidance came in the form of a memorandum issued by former U.S. Deputy Attorney General James Cole on August 29, 2013, which we refer to as the Cole Memorandum. The Cole Memorandum offered guidance to federal agencies on how to prioritize civil enforcement, criminal investigations, and prosecutions regarding marijuana in all states and quickly set a standard with which marijuana-related businesses would comply. The Cole Memorandum put forth eight prosecution priorities: 1. Preventing the distribution of marijuana to minors; 2. Preventing revenue from the sale of marijuana from going to criminal enterprises, gangs, and cartels; 3. Preventing the diversion of marijuana from states where it is legal under state law in some form to other states; 4. Preventing the state-authorized marijuana activity from being used as a cover or pretext for the trafficking of other illegal drugs or other illegal activity; 5. Preventing violence and the use of firearms in the cultivation and distribution of marijuana; 6. Preventing drugged driving and the exacerbation of other adverse public health consequences associated with marijuana use; 7. Preventing the growing of marijuana on public lands and the attendant public safety and environmental dangers posed by marijuana production on public lands; and 8. Preventing marijuana possession or use on federal property. On January 4, 2018, former United States Attorney General Sessions rescinded the Cole Memorandum by issuing a new memorandum to all United States Attorneys, which we refer to as the Sessions Memo. Rather than establishing national enforcement priorities particular to marijuana-related crimes in jurisdictions where certain marijuana activity was legal under state law, the Sessions Memo simply rescinded the Cole Memorandum and other Department of Justice memorandums providing prosecutorial guidance on state and tribally authorized medical and adult-use cannabis activities and instructed that “[i]n deciding which marijuana activities to prosecute... with the [DOJ’s] finite resources, prosecutors should follow the well- established principles that govern all federal prosecutions.” Namely, these include the seriousness of the offense, history of criminal activity, deterrent effect of prosecution, the interests of victims, and other principles. On January 21, 2021, Joseph R. Biden, Jr. was sworn in as President of the United States. President Biden’s Attorney General, Merrick Garland, was confirmed by the United States Senate on March 10, 2021. It is not yet known whether the Department of Justice, under President Biden and Attorney General Garland, will re-adopt the Cole Memorandum or announce a substantive marijuana enforcement policy. During his Senate confirmation, Merrick Garland told Senator Cory Booker (D-NJ), “It does not seem to me useful the use of limited resources that we have to be pursuing prosecutions in states that have legalized and are regulating the use of marijuana, either medically or otherwise.” Such statements are not official declarations or policies of the DOJ and are not binding on the DOJ, any United States Attorney, or the United States federal courts. Substantial uncertainty regarding United States federal enforcement remains. To date, there have been no new federal cannabis memorandums issued by the Biden Administration or any published change in federal enforcement policy. Nonetheless, there is no guarantee that state laws legalizing and regulating the sale and use of marijuana will not be repealed or overturned or that local government authorities will not limit the applicability of state laws within their respective jurisdictions. Unless and until the United States Congress amends the CSA with respect to marijuana (and as to the timing or scope of any such potential amendments, there can be no assurance), there is a risk that federal authorities may enforce current U.S. federal law. Currently, in the absence of uniform federal guidance, as had been established by the Cole Memorandum, enforcement priorities are determined by respective United States Attorneys. As an industry best practice, despite the rescission of the Cole Memorandum, we abide by the following standard operating policies and procedures, which are designed to ensure compliance with the guidance provided by the Cole Memorandum: 1. Continuously monitor our operations for compliance with all licensing requirements as established by the applicable state, county, municipality, town, township, borough, and other political/administrative divisions; 2. Ensure that our cannabis-related activities adhere to the scope of the licensing obtained (for example: in the states where cannabis is permitted only for adult-use, the products are only sold to individuals who meet the requisite age requirements); 3. Implement policies and procedures to prevent the distribution of our cannabis products to minors; 4. Implement policies and procedures in place to avoid the distribution of the proceeds from our operations to criminal enterprises, gangs, or cartels; 5. Implement an inventory tracking system and necessary procedures to reliably track inventory and prevent the diversion of cannabis or cannabis products into those states where cannabis is not permitted by state law or across any state lines in general; 6. Monitor the operations at our facilities so that our state-authorized cannabis business activity is not used as a cover or pretense for trafficking of other illegal drugs or engaging in any other illegal activity; and 7. Implement quality controls so that our products comply with applicable regulations and contain necessary disclaimers about the contents of the products to avoid adverse public health consequences from cannabis use and discourage impaired driving. In addition, we frequently conduct background checks to confirm that the principals and management of our operating subsidiaries are of good character and have not been involved with other illegal drugs, engaged in illegal activity or activities involving violence, or the use of firearms in the cultivation, manufacturing, or distribution of cannabis. We also conduct ongoing reviews of the activities of our cannabis businesses, the premises on which they operate, and the policies and procedures related to the possession of cannabis or cannabis products outside of the licensed premises. Moreover, in recent years, certain temporary federal legislative enactments that protect the medical marijuana and hemp industries have also been in effect. For instance, certain marijuana businesses receive a measure of protection from federal prosecution by operation of temporary appropriations measures that have been enacted into law as amendments (or “riders”) to federal spending bills passed by Congress and signed by Presidents Obama, Trump, and, most recently, President Biden. For instance, in the Appropriations Act of 2015, Congress included a budget “rider” that prohibits DOJ from expending any funds to enforce any law that interferes with a state’s implementation of its own medical marijuana laws. The rider originally known as the “Rohrbacher-Farr” Amendment after its original lead sponsors is now known as the “Joyce” Amendment after its current sponsor. Originally, a Republican-controlled House and Democratic-controlled Senate passed the Rohrbacher-Farr Amendment. The bill was “a bipartisan appropriations measure that looks to prohibit the DEA from spending funds to arrest state-licensed medical marijuana patients and providers.” Subsequently, the rider t has been included in multiple budgets passed by successive Congresses controlled by both major political parties. Most recently, on February 18, 2022, the Amendment was renewed through the signing of an additional stopgap spending bill, H.R.6617 - Further Additional Extending Government Funding Act, effective through March 11, 2022. While the Amendment has been included in successive appropriations legislation or resolutions since 2015, its inclusion or non-inclusion is subject to political change. Notably, Joyce Amendment has applied only to medical marijuana programs and has not provided the same protections to enforcement against adult-use activities. If the Amendment is no longer in effect, the risk of federal enforcement and override of state marijuana laws would increase. In December 2019, an outbreak of a novel strain of coronavirus (COVID-19) originated in Wuhan, China, and has since spread to several other countries, including the United States. On June 11, 2020, the World Health Organization characterized COVID-19 as a pandemic. In addition, as of the time of the filing of this Annual Report on Form 10-K, several states in the United States have declared states of emergency, and several countries around the world, including the United States, have taken steps to restrict travel. The existence of a worldwide pandemic, the fear associated with COVID-19, or any, pandemic, and the reactions of governments in response to COVID-19, or any, pandemic, to regulate the flow of labor and products and impede the travel of personnel, may impact our ability to conduct normal business operations, which could adversely affect our results of operations and liquidity. Disruptions to our supply chain and business operations disruptions to our retail operations and our ability to collect rent from the properties which we own, personnel absences, or restrictions on the shipment of our or our suppliers’ or customers’ products, any of which could have adverse ripple effects throughout our business. If we need to close any of our facilities or a critical number of our employees become too ill to work, our production ability could be materially adversely affected in a rapid manner. Similarly, if our customers experience adverse consequences due to COVID-19, or any other, pandemic, demand for our products could also be materially adversely affected in a rapid manner. Global health concerns, such as COVID-19, could also result in social, economic, and labor instability in the markets in which we operate. Any of these uncertainties could have a material adverse effect on our business, financial condition, or results of operations. These conditions raise substantial doubt as to the Company’s ability to continue as a going concern. Should the United States Federal Government choose to begin enforcement of the provisions under the “ACT”, the Company through its wholly owned subsidiaries could be prosecuted under the “ACT” and the Company may have to immediately cease operations and/or be liquidated upon its closing of the acquisition or investment in entities that engage directly in the production and or sale of cannabis. Management believes that the Company has access to capital resources through potential public or private issuances of debt or equity securities. However, if the Company is unable to raise additional capital, it may be required to curtail operations and take additional measures to reduce costs, including reducing its workforce, eliminating outside consultants, and reducing legal fees to conserve its cash in amounts sufficient to sustain operations and meet its obligations. These matters raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments that might become necessary should the Company be unable to continue as a going concern.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Basis of Presentation The Company’s consolidated financial statements been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All material intercompany accounts and transactions have been eliminated during the consolidation process. The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income, and expenses. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value equity instruments, valuation of its long live assets for impairment testing, valuation of intangible assets, and the valuation of inventory. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable given the circumstances that exist at the time the financial statements are prepared. Actual results may differ materially and adversely from these estimates. To the extent there are material differences between the estimates and actual results, the Company’s future results of operations will be affected. Reclassifications Certain amounts in the Company’s consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods. Principles of Consolidation The Company’s policy is to consolidate all entities that it controls by ownership of a majority of the outstanding voting stock. In addition, the Company consolidates entities that meet the definition of a variable interest entity (“VIE”) for which it is the primary beneficiary. The primary beneficiary is the party who has the power to direct the activities of a VIE that most significantly impact the entity’s economic performance and who has an obligation to absorb losses of the entity or a right to receive benefits from the entity that could potentially be significant to the entity. For consolidated entities that are less than wholly owned, the third party’s holding of equity interest is presented as noncontrolling interests in the Company’s Consolidated Balance Sheets and Consolidated Statements of Changes in Stockholders’ Equity. The portion of net loss attributable to the noncontrolling interests is presented as net loss attributable to noncontrolling interests in the Company’s Consolidated Statements of Operations. The accompanying consolidated financial statements include the accounts of Stem Holdings, Inc. and its wholly owned subsidiaries, Stem Holdings Oregon, Inc., Stem Holdings IP, Inc., Opco, LLC, Stem Holdings Agri, Inc., Stem Oregon Acquisitions 2 Corp., Stem Oregon Acquisitions 3 Corp., Stem Oregon Acquisitions 4 Corp., 7LV USA Corporation, and Stem Oregon Acquisitions 1 Corp., and Driven Deliveries, Inc., which was subsequently divested. In addition, the Company has consolidated YMY Ventures, WCV, LLC and NVD RE, Inc. under the variable interest requirements. Cash and Cash Equivalents The Company considers all highly liquid investments with a maturity of three months or less at the time of purchase to be cash equivalents. Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents. The Company’s cash is primarily maintained in checking accounts. These balances may, at times, exceed the U.S. Federal Deposit Insurance Corporation insurance limits. As of September 30, 2022, and 2021, the Company had no cash equivalents or short-term investments. The Company has not experienced any losses on deposits of cash and cash equivalents. Accounts Receivable Accounts receivable is shown on the face of the consolidated balance sheets, net of an allowance for doubtful accounts. The Company analyzes the aging of accounts receivable, historical bad debts, customer creditworthiness and current economic trends, in determining the allowance for doubtful accounts. The Company does not accrue interest receivable on past due accounts receivable. As of September 30, 2022, and 2021 the reserve for doubtful accounts was $ 79 Inventory Inventory is comprised of raw materials, finished goods and work-in-progress such as pre-harvested cannabis plants and by-products to be extracted. The costs of growing cannabis including but not limited to labor, utilities, nutrition, and irrigation, are capitalized into inventory until the time of harvest. The Company recorded an adjustment to reduce inventory to net realizable value of $ 88 0 Inventory is stated at the lower of cost or net realizable value, determined using weighted average cost. Cost includes expenditures directly related to manufacturing and distribution of the products. Primary costs include raw materials, packaging, direct labor, overhead, shipping and the depreciation of manufacturing equipment and production facilities determined at normal capacity. Manufacturing overhead and related expenses include salaries, wages, employee benefits, utilities, maintenance, and property taxes. Net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. At the end of each reporting period, the Company performs an assessment of inventory obsolescence to measure inventory at the lower of cost or net realizable value. Factors considered in the determination of obsolescence include slow-moving or non-marketable items. Prepaid Expenses and Other Current Assets Prepaid expenses consist of various payments that the Company has made in advance for goods or services to be received in the future. These prepaid expenses include consulting, advertising, insurance, and service or other contracts requiring up-front payments. Property and Equipment Property, equipment, and leasehold improvements are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets Expenditures for major renewals and improvements are capitalized, while minor replacements, maintenance, and repairs, which do not extend the asset lives, are charged to operations as incurred. Upon sale or disposition, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operations. The Company continually monitors events and changes in circumstances that could indicate that the carrying balances of its property, equipment and leasehold improvements may not be recoverable in accordance with the provisions of ASC 360, “Property, Plant, and Equipment.” When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. See “Note 3 – Property, Equipment and Leasehold Improvements”. Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided on a straight-line method over the estimated useful lives of the assets. The Company estimates useful lives as follows: Schedule of Estimated Useful Life of Assets Buildings 20 Leasehold improvements Shorter of term of lease or economic life of improvement Furniture and equipment 5 Signage 5 Software and related 5 Impairment of Long-Lived Assets The Company reviews the carrying value of its long-lived assets, which include property and equipment, for indicators of impairment whenever events or changes in circumstances indicate that the carrying value of an asset or asset group may not be recoverable. The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i) significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in the Company’s overall strategy with respect to the manner or use of the acquired assets or changes in the Company’s overall business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant decline in the Company’s stock price for a sustained period of time; and (vi) regulatory changes. The Company evaluates assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events. The Company does not test for impairment in the year of acquisition of properties, as long as those properties are acquired from unrelated third parties. The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts. In cases where estimated future net undiscounted cash flows are less than the carrying value, an impairment loss is recognized equal to an amount by which the carrying value exceeds the fair value of the asset or asset group. Fair value is generally determined using the assets expected future discounted cash flows or market value, if readily determinable. If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated and amortized prospectively over the newly determined remaining estimated useful lives. Equity Method Investments Investments in unconsolidated affiliates are accounted for under the equity method of accounting, as appropriate. The Company accounts for investments in limited partnerships or limited liability corporations, whereby the Company owns a minimum of 5.0 During the years ended September 30, 2022, and 2021, the Company recognized its share of investee losses of approximately $ 0 234 233 1 Investments were impaired by $ 795 2.2 Asset Acquisitions The Company has adopted ASU 2017-01, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as businesses acquisitions. As a result of adopting ASU 2017-01, acquisitions of real estate and cannabis licenses do not meet the definition of a business combination and were deemed asset acquisitions, and the Company therefore capitalized these acquisitions, including its costs associated with these acquisitions. Goodwill and Intangible Assets Goodwill. 5.9 0 Intangible Assets 1,961 0 An intangible asset with an indefinite useful life is not amortized but assessed for impairment annually, or more frequently, when events or changes in circumstances occur indicating that it is more likely than not that the indefinite-lived asset is impaired. Impairment exists when the carrying amount exceeds its fair value. In testing for impairment, the Company has the option to first perform a qualitative assessment to determine whether it is more likely than not that an impairment exists. If it is determined that it is not more likely than not that an impairment exists, a quantitative impairment test is not necessary. If the Company concludes otherwise, it is required to perform a quantitative impairment test. To the extent an impairment loss is recognized, the loss establishes the new cost basis of the asset that is amortized over the remaining useful life of that asset, if any. Subsequent reversal of impairment losses is not permitted. Business Combinations The Company applies the provisions of ASC 805 in the accounting for acquisitions. ASC 805 requires the Company to recognize separately from goodwill the assets acquired, and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions to accurately apply preliminary value to assets acquired and liabilities assumed at the acquisition date as well as contingent consideration, where applicable, these estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments in the current period, rather than a revision to a prior period. Upon the conclusion of the measurement period or final determination of the values of the assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded in the consolidated statements of operations. Accounting for business combinations requires management to make significant estimates and assumptions, especially at the acquisition date, including estimates for intangible assets, contractual obligations assumed, restructuring liabilities, pre-acquisition contingencies, and contingent consideration, where applicable. Although the Company believes the assumptions and estimates made have been reasonable and appropriate, they are based in part on historical experience and information obtained from management of the acquired companies and are inherently uncertain. Unanticipated events and circumstances may occur that may affect the accuracy or validity of such assumptions, estimates, or actual results. Contingent Consideration The Company accounts for “contingent consideration” according to FASB ASC 805, “Business Combinations” (“FASB ASC 805”). Contingent consideration typically represents the acquirer’s obligation to transfer additional assets or equity interests to the former owners of the acquiree if specified future events occur or conditions are met. FASB ASC 805 requires that contingent consideration be recognized at the acquisition-date fair value as part of the consideration transferred in the transaction. FASB ASC 805 uses the fair value definition in Fair Value Measurements, which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As defined in FASB ASC 805, contingent consideration is (i) an obligation of the acquirer to transfer additional assets or equity interests to the former owners of an acquiree as part of the exchange for control of the acquiree, if specified future events occur or conditions are met or (ii) the right of the acquirer to the return of previously transferred consideration if specified conditions are met. Warrant Liability The Company accounts for certain common stock warrants outstanding as a liability at fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s consolidated statements of operations. The fair value of the warrants issued by the Company has been estimated using a Black Scholes model. Embedded Conversion Features The Company evaluates embedded conversion features within convertible debt to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in the statement of operations. If the conversion feature does not require recognition of a bifurcated derivative, the convertible debt instrument is evaluated for consideration of any beneficial conversion feature (“BCF”) requiring separate recognition. When the Company records a BCF, the intrinsic value of the BCF is recorded as a debt discount against the face amount of the respective debt instrument (offset to additional paid-in capital) and amortized to interest expense over the life of the debt. Income Taxes The provision for income taxes is determined in accordance with ASC 740, “Income Taxes”. The Company files a consolidated United States federal income tax return. The Company provides for income taxes based on enacted tax law and statutory tax rates at which items of income and expense are expected to be settled in our income tax return. Certain items of revenue and expense are reported for Federal income tax purposes in different periods than for financial reporting purposes, thereby resulting in deferred income taxes. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company has incurred net operating losses for financial-reporting and tax-reporting purposes. As of September 30, 2022, and 2021, such net operating losses were offset entirely by a valuation allowance. The Company recognizes uncertain tax positions based on a benefit recognition model. Provided that the tax position is deemed more likely than not of being sustained, the Company recognizes the largest amount of tax benefit that is greater than 50.0% likely of being ultimately realized upon settlement. The tax position is derecognized when it is no longer more likely than not of being sustained. The Company classifies income tax related interest and penalties as interest expense and selling, general and administrative expense, respectively, on the consolidated statements of operations. In December 2017, the Tax Cuts and Jobs Act (TCJA or the Act) was enacted, which significantly changes U.S. tax law. In accordance with ASC 740, “Income Taxes”, the Company is required to account for the new requirements in the period that includes the date of enactment. The Act reduced the overall corporate income tax rate to 21.0 Revenue Recognition The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of Accounting Standards Codification (ASC) Topic 606, Revenue from Contracts with Customers (Topic 606), the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of Topic 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Revenue for the Company’s product sales has not been adjusted for the effects of a financing component as the Company expects, at contract inception, that the period between when the Company’s transfers control of the product and when the Company receives payment will be one year or less. Product shipping and handling costs are included in cost of product sales. The following policies reflect specific criteria for the various revenue streams of the Company: Cannabis Dispensary, Cultivation and Production Revenue is recognized upon transfer of retail merchandise to the customer upon sale transaction, at which time its performance obligation is complete. Revenue is recognized upon delivery of product to the wholesale customer, at which time the Company’s performance obligation is complete. Terms are generally between cash on delivery to 30 days for the Company’s wholesale customers. The Company’s sales environment is somewhat unique, in that once the product is sold to the customer (retail) or delivered (wholesale) there are essentially no returns allowed or warranty available to the customer under the various state laws. Delivery 1) Identify the contract with a customer The Company sells retail products directly to customers. In these sales there is no formal contract with the customer. These sales have commercial substance and there are no issues with collectability as the customer pays the cost of the goods at the time of purchase or delivery. 2) Identify the performance obligations in the contract The Company sells its products directly to consumers. In this case these sales represent a performance obligation with the sales and any necessary deliveries of those products. 3) Determine the transaction price The sales that are done directly to the customer have no variable consideration or financing component. The transaction price is the cost that those goods are being sold for plus any additional delivery costs. 4) Allocate the transaction price to performance obligations in the contract For the goods that the Company sells directly to customers, the transaction price is allocated between the cost of the goods and any delivery fees that may be incurred to deliver to the customer. 5) Recognize revenue when or as the Company satisfies a performance obligation For the sales of the Company’s own goods the performance obligation is complete once the customer has received the product. Leases On October 1, 2020, the Company adopted ASC 842 and elected to apply the new standard at the adoption date and recognize a cumulative effect as an adjustment to retained earnings. Upon calculation the effect on retained earnings was immaterial and no adjustment was deemed necessary. Leases with an initial term of twelve months or less are not recorded on the balance sheet. For lease agreements entered into or reassessed after the adoption of Topic 842, we combine the lease and non-lease components in determining the lease liabilities and right of use (“ROU”) assets. Our lease agreements generally do not provide an implicit borrowing rate; therefore, an internal incremental borrowing rate is determined based on information available at lease commencement date for purposes of determining the present value of lease payments. We used the incremental borrowing rate on September 30, 2022, for all leases that commenced prior to that date. In determining this rate, which is used to determine the present value of future lease payments, we estimate the rate of interest we would pay on a collateralized basis, with similar payment terms as the lease and in a similar economic environment. Under Topic 842, operating lease expense is generally recognized evenly over the term of the lease. Lease costs were $ 1,224 599 0 17 4 177 Lease Costs Schedule of Lease Costs Year Ended September 30, 2022 Components of total lease costs: Operating lease expense $ 1,224 Total lease costs $ 1,224 Lease positions as of September 30, 2022 ROU lease assets and lease liabilities for our operating leases were recorded in the consolidated condensed balance sheet as follows: Schedule of Right-of-Use Assets and Lease Liabilities September 30, 2022 Assets Right of use asset $ 6,874 Total assets $ 6,874 Liabilities Operating lease liabilities – short term $ 580 Operating lease liabilities – long term 6,476 Total lease liability $ 7,056 Lease Terms and Discount Rate Schedule of Lease Terms and Discount Rate Weighted average remaining lease term (in years) – operating lease 12.23 Weighted average discount rate – operating lease 11.04 % Cash Flows Schedule of Cash Flow Related to Lease Year Ended September 30, 2022 Cash paid for amounts included in the measurement of lease liabilities: ROU amortization $ 1,224 Cash paydowns of operating liability $ (1,224 ) Supplemental non-cash amounts of lease liabilities arising from obtaining: ROU asset $ 6,874 Lease Liability $ 7,056 The future minimum lease payments under the leases are as follows: Schedule of Future Minimum Lease Payments 2022 2023 $ 1,337 2024 1,147 2025 1,053 2026 1,033 2027 825 Thereafter 8,345 Total future minimum lease payments 13,740 Less: Lease imputed interest (6,684 ) Total $ 7,056 Disaggregation of Revenue In the year ended September 30, 2022, and 2021, revenue reported was primarily from the sale of cannabis and related products accounted for under ASC 606. The following table illustrates our revenue by type related to the years ended September 30, 2022, and 2021: Schedule of Disaggregation of Revenue 2022 2021 September 30, 2022 2021 Revenue Wholesale $ 4,306 $ 5,270 Retail 14,867 18,432 Rental - 17 Other 118 692 Total revenue 19,291 24,411 Discounts and returns (2,728 ) (3,474 ) Net Revenue $ 16,563 $ 20,937 Geographical Concentrations As of September 30, 2022, the Company is primarily engaged in the production and sale of cannabis, which is only legal for recreational use in 19 states and D.C., with lesser legalization, such as for medical use in an additional 21 states and D.C., as of the time of these consolidated financial statements. In addition, the United States Congress has passed legislation, specifically the Agriculture Improvement Act of 2018 (also known as the “Farm Bill”) that has removed production and consumption of hemp and associated products from Schedule 1 of the Controlled Substances Act. Cost of Goods Sold Cost of sales represents costs directly related to manufacturing and distribution of the Company’s products. Primary costs include raw materials, packaging, direct labor, overhead, shipping and handling and the depreciation of manufacturing equipment and production facilities. Manufacturing overhead and related expenses include salaries, wages, employee benefits, utilities, maintenance, and property taxes. The Company recognizes the cost of sales as the associated revenues are recognized. Fair Value of Financial Instruments As defined in the authoritative guidance, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To estimate fair value, the Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated or generally unobservable. The authoritative guidance establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (“Level 1” measurements) and the lowest priority to unobservable inputs (“Level 3” measurements). The three levels of the fair value hierarchy are as follows: Level 1 — Observable inputs such as quoted prices in active markets at the measurement date for identical, unrestricted assets or liabilities. Level 2 — Other inputs that are observable, directly, or indirectly, such as quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability. Level 3 — Unobservable inputs for which there is little or no market data and which the Company makes its own assumptions about how market participants would price the assets and liabilities. In instances in which multiple levels of inputs are used to measure fair value, hierarchy classification is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. Stock-based Compensation The Company accounts for share-based payment awards exchanged for services at the estimated grant date fair value of the award. Stock options issued under the Company’s long-term incentive plans are granted with an exercise price equal to no less than the market price of the Company’s stock at the date of grant and expire up to ten years from the date of grant. These options generally vest on the grant date or over a one-year period. The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model and the assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. Expected Term Expected Volatility Risk-Free Interest Rate Expected Dividend Effective January 1, 2017, the Company elected to account for forfeited awards as they occur, as permitted by Accounting Standards Update (“ASU”) 2016-09. Ultimately, the actual expenses recognized over the vesting period will be for those shares that vested. Prior to making this election, the Company estimated a forfeiture rate for awards at 0%, as the Company did not have a significant history of forfeitures. Earnings (Loss) per Share ASC 260, Earnings Per Share, requires dual presentation of basic and diluted earnings per share (“EPS”) with a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. Basic EPS excludes dilution. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the entity. Basic net loss per share of common stock excludes dilution and is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share of common stock reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the entity unless inclusion of such shares would be anti-dilutive. Since the Company has only incurred losses, basic and diluted net loss per share is the same. Securities that could potentially dilute loss per share in the future that were not included in the computation of diluted loss per share as of September 30, 2022, and 2021 are as follows: Schedule of Computation of Diluted Loss Potentially dilutive share-based instruments: September 30, September 30, 2022 2021 Convertible notes 34,736,220 3,696,311 Options to purchase common stock 5,518,185 7,140,447 Unvested restricted stock awards - - Warrants to purchase common stock 65,783,059 62,965,833 Anti-dilutive Securities 106,037,464 73,802,591 Advertising Costs The Company follows the policy of charging the cost of advertising to expense as incurred. Advertising expense was $ 266 368 Related parties Parties are related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal with if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. Segment reporting Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision–making group in deciding how to allocate resou

Discontinued Operations, Assets

Discontinued Operations, Assets and Liabilities Held for Sale	12 Months Ended
	Sep. 30, 2022
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations, Assets and Liabilities Held for Sale	3. Discontinued Operations, Assets and Liabilities Held for Sale Discontinued Operations On December 15, 2021, pursuant to a Share Exchange Agreement, the Company sold Driven Deliveries and its subsidiaries to the shareholders of Budee, Inc. in a transaction which the Company fully divested all of its interests in Driven Deliveries and all of its subsidiaries. Included in the terms of the Share Exchange Agreement, the shareholder of Budee, Inc., and prior officer of Driven Deliveries returned approximately 11.5 7.1 210,000 130 The following table presents the assets and liabilities associated with the divestiture of Driven Deliveries; Inc. as follows (in thousands): Schedule of Discontinued Operations of Assets and Liabilities December 15, September 30, 2021 2021 ASSETS Current assets Cash and cash equivalents $ 47 $ 106 Inventory 509 382 Prepaid expenses and other current assets 242 887 Total current assets 798 1,375 Property and equipment, net 4 12 Right of use asset 327 328 Intangible assets, net 7,049 7,609 Total assets $ 8,178 $ 9,324 LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities Accounts payable and accrued expenses 7,551 5,967 Short term notes and advances 3 7 Settlement payable - 92 Acquisition notes payable - 409 Lease liability 218 218 Total current liabilities 7,772 6,693 Lease liability - long term 108 108 Total liabilities $ 7,880 $ 6,801 The total assets and total liabilities in the above table for the year ended September 30, 2021, are presented in the balance sheet as of September 30, 2022, as Assets held for sale and Liabilities held for sale. The following table presents the operating results related to the divestiture of Driven Deliveries; Inc. (in thousands): 2022 2021 Year Ended September 30, 2022 2021 Revenues $ 3,805 $ 14,832 Cost of goods sold 3,772 13,796 Gross Profit 33 1,036 Operating expenses: Consulting fees 4 115 Professional fees 24 275 General and administration 1,749 4,643 Impairment expense - 50,255 Total operating expenses 1,777 55,288 Loss from operations (1,744 ) (54,251 ) Other income (expenses) Interest expense (1 ) - Other income - 155 Total other income (expense) (1 ) 155 Net loss $ (1,745 ) $ (54,096 )

Property, Plant & Equipment

Property, Plant & Equipment	12 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Property, Plant & Equipment	4. Property, Plant & Equipment Property and equipment consist of the following (in thousands): Schedule of Property, Plant and Equipment September 30, September 30, 2022 2021 Land $ 1,151 $ 1,451 Automobiles 93 74 Signage 19 19 Furniture and equipment 2,590 3,033 Leasehold improvements 3,532 3,474 Buildings and property improvements 7,460 10,126 Computer software 59 56 Property and equipment, gross 14,904 18,233 Accumulated depreciation (5,815 ) (5,635 ) Property and equipment, net $ 9,089 $ 12,598 Depreciation expense was approximately $ 1.61 1.93

Inventory

Inventory	12 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Inventory	5. Inventory Inventory consists of the following (in thousands): Schedule of Inventory September 30, September 30, 2022 2021 Raw materials $ 569 $ 866 Work-in-progress 450 543 Finished goods 1,656 1,717 Total Inventory $ 2,675 $ 3,126 Raw materials and work-in-progress include the costs incurred for cultivation materials and live plants. Finished goods consists of cannabis products sent to retail locations or ready to be sold. No

Prepaid expenses and other curr

Prepaid expenses and other current assets	12 Months Ended
	Sep. 30, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid expenses and other current assets	6. Prepaid expenses and other current assets Prepaid expenses and other current assets are assets and payments previously made, that benefit future periods. The balance as of September 30, 2022, includes the Employee Retention Tax Credit (“ERTC”) program from the U.S Treasury, as part of the COVID-19 stimulus package. During the fiscal year ended September 30, 2021, the Company applied for certain ERTC credits in the approximate amount of $ 5.1 201 Prepaid and other current assets comprised of the following: Schedule of Prepaid Expenses and Other Current Assets September 30, September 30, 2022 2021 Prepaid expenses $ 538 $ 732 ERTC credits 201 605 Deposits and other current assets 190 850 Total prepaid expenses and other current assets $ 929 $ 2,187

Equity method investments

Equity method investments	12 Months Ended
	Sep. 30, 2022
Equity Method Investments and Joint Ventures [Abstract]
Equity method investments	7. Equity method investments Tilstar Medical, LLC In April 2019, the Company entered into an agreement to acquire 48 48 550,000 550,000 288,000 Community Growth Partners, Inc On January 6, 2020, the Company issued a convertible promissory note to Community Growth Partners Holdings, Inc., (“CGS”) which acted as a line of credit. Subject to the terms and conditions of the note, CGS promised to pay the Company all of the outstanding principal together with interest on the unpaid principal balance upon the date that is twelve months after the effective date and was payable as follows: (a)The Company agreed to make several loans to CGS from time to time upon request of CGS in amounts not to exceed the principal sum of $ 2,000,000 2,000,000 7 6 13 1.65 488

Note Receivable

Note Receivable	12 Months Ended
	Sep. 30, 2022
Receivables [Abstract]
Note Receivable	8. Note Receivable On January 4, 2020, the Company issued a $ 355,000 150,000 1.65 On January 6, 2020, the Company issued a convertible non-negotiable revolving credit promissory note up to $ 2,500,000 four-year 2,500,000 899,700 480,182 7 30,000 6 1.65 In September 2020 a former employee received funds on behalf of the Company. On October 1, 2020, the Company executed a $ 14 thousand promissory note to memorialize and structure a plan to receive the funds from the individual. The note was non-interest bearing and was to be paid in equal monthly installments over an eighteen-month term with a maturity date of March 1, 2022 . As of September 30, 2022, and September 30, 2021, the principal balance of the note was $ 0 and $ 3 thousand, respectively. On October 1, 2020, the Company issued a $ 100,000 210,000 310,000 On April 5, 2021, the Company issued a $ 250,000 The Note has a maturity date which is six months after the close of the Arkannabis, a Colorado grow facility 5.75 The terms of the note call for automatic conversion upon the closing of the Arkannabis business of the outstanding principal and interest on this Note and will convert into that number of shares of the equity securities equivalent to a non-dilutive 12.5% of the issued and outstanding shares of the Arkannabis business 257,010

Consolidated Asset Acquisitions

Consolidated Asset Acquisitions	12 Months Ended
	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Consolidated Asset Acquisitions	9. Consolidated Asset Acquisitions West Coast Ventures On March 29, 2019, the Company entered into a definitive agreement to acquire Western Coast Ventures, Inc. (“WCV”). At the time of acquisition, WCV was a shell with cash of $ 2,000,000 51 2,500,000 4.4 1.47 2.0 2.4 2.2 Michigan RE 1 On January 4, 2021, the Company entered into a Securities Purchase Agreement (“SPA”) with Michigan RE 1, Inc. (“MRE1”) pursuant to a private placement offering of up to an aggregate amount of $ 510 comprising up to 510 shares of MRE1’s common stock which represents 51 % ownership by the Company. On January 5, 2021, the Company was party to an Asset Purchase Agreement between Leoni Wellness, LLC (“Seller”) and Organic Guyz, LLC (“Purchaser”) whereas the Seller is engaged in the recreational cannabis business and the Purchaser desired to purchase the local municipal license to operate an adult use retailer in the City of Kalamazoo, Michigan. The purchase price to be paid by the Purchaser was $ 400,000 . 507 Kaya Holdings, Corp. On April 13, 2021, the Company executed an Investors’ Rights Agreement in conjunction with a Subscription Agreement with Kaya Holdings, Corp. The Company purchased 2,875,000 230,000 500,000 3,375,000 200,000 30,000

Non-Controlling Interests

Non-Controlling Interests	12 Months Ended
	Sep. 30, 2022
Noncontrolling Interest [Abstract]
Non-Controlling Interests	10. Non-Controlling Interests Non-controlling interests in consolidated entities are as follows (in thousands): Schedule of Non-Controlling Interests in Consolidated Entities As of September 30, 2021 NCI Equity Share Net Loss Attributable to NCI NCI in Consolidated Entities Non-Controlling Ownership % NVD RE Corp. $ 587 $ (34 ) $ 553 36.2 % Western Coast Ventures, Inc. 1,052 (210 ) 842 49.0 % YMY Ventures, Inc. 243 56 299 50.0 % Michigan RE 1, Inc. - (54 ) (54 ) 49.0 % $ 1,882 $ (242 ) $ 1,640 As of September 30, 2022 NCI Equity Share Net Loss Attributable to NCI NCI in Consolidated Entities Non-Controlling Ownership % NVD RE Corp. $ 553 $ (37 ) $ 516 36.2 % Western Coast Ventures, Inc. 842 $ (3 ) 839 49.0 % YMY Ventures, Inc. 299 $ 30 329 50.0 % Michigan RE 1, Inc. (54 ) $ (152 ) (206 ) 49.0 % $ 1,640 $ (162 ) $ 1,478

Business Combination

Business Combination	12 Months Ended
	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Business Combination	11. Business Combination Driven Deliveries, Inc. In December 2020, the Company, through an Agreement and Plan of Merger became the parent of an 100 101,968,944 4,530,495 30,249,184 .45 The table below shows the warrant liability and embedded derivative liability recorded in connection with the Driven convertible notes and the subsequent fair value measurement during the year ended September 30, 2021 in USD, ( in thousands Schedule of Liabilities Measured at Fair Value Warrant Liability Derivative Liability Balance as of September 30, 2020 $ - $ - Warrants acquired 9,000 - Warrants converted into equity (4,589 ) - Change in fair value (2,415 ) - Balance as of September 30, 2021 $ 1,996 $ - Purchase Price Allocation As of December 29, 2020, the Company allocated the purchase consideration to the fair value of the assets acquired and liabilities assumed as summarized in the table below ( Consideration Paid (in thousands) Schedule of Purchasre Consideration to Fair value of assets Aquired and Liabilities Assumed Consideration Paid (in thousands) Estimated fair value of common stock issued $ 40,048 Estimated fair value of warrants issued 9,000 Estimated fair value of options issued 500 Estimated fair value of debt assumed 4,389 Total consideration paid $ 53,937 Assets acquired: (in thousands) Cash and cash equivalents $ - Fixed assets 47 Other Assets 1,526 Goodwill 11,740 Intangible assets 47,900 Total assets acquired $ 61,213 Liabilities assumed: (in thousands) Accrued expenses and other current liabilities (7,276 ) Total liabilities assumed $ (7,276 ) Net assets acquired (in thousands) $ 53,937 The goodwill of $ 11,740,000 Based on a review of long-lived tangible and intangible asset, and goodwill, an impairment expense of $ 52.5 On December 17, 2021, pursuant to a Share Exchange Agreement, the Company sold Driven Deliveries and its subsidiaries to the shareholders of Budee, Inc. in a transaction which STEM fully divested its interest in Driven Deliveries and its subsidiaries. Included in the terms of the Share Exchange Agreement, the shareholders of Budee, and a prior officer of Driven Deliveries returned approximately 11.5 7.9 210,753 During the year ended September 30, 2021, the Company also recorded adjustments for the elimination of other investments totaling $ 1.715 Artifact On September 17, 2021, pursuant to an Agreement and Plan of Reorganization (“Agreement”) the Company acquired a marijuana processor business and a marijuana retailer business located in Eugene, Oregon; a marijuana retailer business located in Salem, Oregon; and certain intellectual property assets, including but not limited to the “ARTIFACT EXTRACTS” trademark that is used by the retail businesses acquired in connection with the Agreement. In connection with the Agreement, the Company acquired fixed assets and intangible assets in exchange for 8,209,178 2,380,661 0.29 Purchase Price Allocation As of September 17, 2021, the Company allocated the purchase consideration to the fair value of the assets acquired and liabilities assumed as summarized in the table below ( Schedule of Purchase Consideration to Fair value of assets Acquired and Liabilities Assumed Purchase Consideration Stock Consideration $ 2,381 Total Purchase Consideration $ 2,381 Allocation of Purchase Consideration Working Capital $ 189 Fixed Assets 14 Customer Relationships 3 License 1,762 Tradename 206 Goodwill 207 Total Purchase Consideration $ 2,381 The goodwill of $ 207,000 The following unaudited proforma condensed consolidated results of operations have been prepared as if the acquisition above occurred October 1, 2020. Schedule of Unaudited Proforma Information Year Ended September 30, 2021 Revenue $ 43,821 Net loss $ (75,427 ) The unaudited proforma condensed consolidated results of operations are not necessarily indicative of results that would have occurred had the acquisitions occurred as of October 1, 2021, nor are they necessarily indicative of the results that may occur in the future.

Intangible Assets, net

Intangible Assets, net	12 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets, net	12. Intangible Assets, net Intangible assets as of September 2021, and 2020 (in thousands): Schedule of Intangible Assets Estimated Useful Life Cannabis Licenses Tradename Customer Relationship Non-compete Technology Accumulated Amortization Net Carrying Amount Balance as September 30, 2021 $ 20,092 $ 951 $ 645 $ 220 $ 418 $ (3,861 ) $ 18,465 YMY Ventures 15 - - - - - (49 ) (49 ) Western Coast Ventures, Inc. 15 - - - - - - - Yerba Buena 3 15 (1,238 ) - - - - 386 (852 ) Foothill (7LV) 15 - - - - - (523 ) (523 ) Driven Deliveries (See Note 3) 10 15 (9,315 ) (413 ) - - (413 ) 2,533 (7,608 ) JV Retail 3 3 15 (391 ) (129 ) - - - 16 (504 ) JV Retail 4 3 15 (391 ) (129 ) - - - 18 (502 ) JV Extraction 10 15 (392 ) - - - - (21 ) (413 ) Other 5 - - - - - - - Balance as September 30, 2022 $ 8,365 $ 280 $ 645 $ 220 $ 5 $ (1,501 ) $ 8,014 Actual amortization expense to be reported in future periods could differ from these estimates as a result of new intangible asset acquisitions, changes in useful lives or other relevant factors or changes. Amortization expense for the years ended September 30, 2022, and 2021 was $ 881 3,460 The following table is a runoff of expected amortization in the following 5-year period as of September 30: Schedule of Expected Amortization 2023 $ 680 2024 680 2025 680 2026 680 2027 680 Thereafter 4,614 Intangible assets $ 8,014

Accounts payable and accrued ex

Accounts payable and accrued expenses	12 Months Ended
	Sep. 30, 2022
Payables and Accruals [Abstract]
Accounts payable and accrued expenses	13. Accounts payable and accrued expenses Accounts payable and accrued expenses consist of the following (in thousands): Schedule of Accounts Payable and Accrued Expenses September 30, September 30, 2022 2021 Accounts payable 1,790 $ 1,105 Accrued credit cards 14 25 Accrued interest 111 87 Accrued payroll 109 713 Accrued sales tax liability 120 148 Other 166 469 Total Accounts Payable and Accrued Expenses $ 2,310 $ 2,547

Notes Payable and Advances

Notes Payable and Advances	12 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Notes Payable and Advances	14. Notes Payable and Advances The following table summarizes the Company’s short-term notes and advances, acquisition note payable, due to related party loans, and long-term debt, mortgages as of September 30, 2022, and 2021: Schedule of Short-term Notes and Advances September 30, September 30, 2022 2021 Equipment financing $ 20 $ 30 Insurance financing 230 261 Promissory note 201 359 Total notes payable and advances $ 451 $ 650 Current portion of long-term debt $ 1,000 $ - Long-term mortgages, net of current portion 1,225 2,100 Total long-term debt, net of current portion $ 2,225 $ 2,100 Equipment financing Effective April 29, 2018, the Company entered into a 36-month premium finance agreement in consideration for a John Deere Gator Tractor in the principal amount of $ 15,710 442 0 Pursuant to the Company’s acquisition of Yerba Buena the Company assumed a note payable obligation dated July 2017 related to a tractor which had a 60-month premium finance agreement. The principal amount was $ 28,905 482 0 January 2021, the Company entered into a promissory note in the amount of $ 27,880 13.29 642 20,465 Insurance financing Effective February 17, 2021, the Company entered into a 12-month premium finance agreement in partial consideration for an insurance policy in the principal amount of $ 243,284 7.46 47,100 17,835 Effective December 4, 2020, the Company entered into a 10-month premium finance agreement in partial consideration for an insurance policy in the principal amount of $ 9,920 12.8 2,383 754 Effective February 24, 2021, the Company entered into a 12-month premium finance agreement in partial consideration for an insurance policy in the principal amount of $ 13,694 7.369 3,424 1,199 Effective April 10, 2021, the Company entered into a 12-month premium finance agreement for an insurance policy in the principal amount of $ 78,750 8.35 15,750 7,271 Effective April 17, 2021, the Company entered into a 12-month premium finance agreement for an insurance policy in the principal amount of $ 23,014 11.98 4,871 1,814 Effective May 31, 2021, the Company entered into a 12-month premium finance agreement for an insurance policy in the principal amount of $ 8,906 10.25 2,537 741 Effective July 16, 2021, the Company entered into a 12-month premium finance agreement for an insurance policy in the principal amount of $ 11,830 1.06 4,113 771 Effective July 17, 2021, the Company entered into a 12-month premium finance agreement for an insurance policy in the principal amount of $ 16,850 3.96 1,351 Effective August 30, 2021, the Company entered into a 12-month premium finance agreement for an insurance policy in the principal amount of $ 58,899 7.99 17,769 4,113 94,116 11.26 27,102 7,446 12,188 Effective October 26, 2021, the Company entered into a 12-month premium finance agreement for an insurance policy in the principal amount of $ 10,411 10.65 1,751 866 Effective February 9, 2022, the Company entered into a 12-month premium finance agreement in partial consideration for an insurance policy in the principal amount of $ 430,657 7.64 86,131 35,795 107,386 Effective February 24, 2022, the Company entered into a 12-month premium finance agreement in partial consideration for an insurance policy in the principal amount of $ 17,551 7.37 18,033 1,327 3,981 Effective April 6, 2022, the Company entered into a 12-month premium finance agreement in partial consideration for an insurance policy in the principal amount of $ 29,060 9.65 5,812 2,697.47 10,790 Effective May 23, 2022, the Company entered into a 12-month premium finance agreement in partial consideration for an insurance policy in the principal amount of $ 7,599 11.50 2,121 640.41 3,842 Effective April 5, 2022, the Company entered into a 12-month premium finance agreement in partial consideration for an insurance policy in the principal amount of $ 20,931 10.50 5,347 1,808.22 7,233 Effective July 7, 2022, the Company entered into a 12-month premium finance agreement for an insurance policy in the principal amount of $ 10,150 11 3,950 837 5,861 Effective July 31, 2022, the Company entered into a 12-month premium finance agreement for an insurance policy in the principal amount of $ 144,500 9.49 35,803 11,348 90,784 Promissory note In January 2020, the Company issued two promissory notes with a principal balance of $ 500,000 12 100,000 five 0.85 As of July 2020, in consideration of the warrants being amended to $ 0.45 five ten 425,000 358,996 66,004 250,000 200,548 49,452 In April 2022, the Company has completed a private placement of a $ 500,000 500,000 5,000 10 0.07 250,000 250,000 250,000 In January 2020, the Company issued two promissory notes with a principal balance of $ 500,000 12 five 0.85 As of July 2020, in consideration of the warrants being amended to $ 0.45 five ten 20,000 In July 2020, the Company’s wholly owned subsidiary in Oregon received loan proceeds of $ 220,564 220,565 The Company received loan proceeds of $ 266,820 266,820 The Company’s related entity received loan proceeds of $ 245,400 June 03, 2022 245,400 The Company’s subsidiary received loan proceeds of $ 62,500 62,500 The Company’s subsidiary received loan proceeds of $ 140,407 140,407 Settlement payable As part of the Agreement and Plan of Merger with Driven Deliveries the Company assumed a settlement payable related to an employment claim where Driven shall pay certain employees a total of $ 250,451 This settlement is payable in equal bi-monthly payments over a period of seventeen (17) Months (36 pay periods), beginning in February 2021 92,045 Long-term debt, mortgages In January 2020, the Company refinanced a mortgage payable on property located in Oregon to acquire additional funds. The mortgage bears interest at 15 January 31, 2022 The note has been cross guaranteed by the former CEO and Director of the Company 400,000 450,000 12 three-year term In March 2020, the Company executed a $ 400,000 11.55 April 1, 2022 38,000 400,000 In March 2020, the Company refinanced a mortgage payable on property located in Oregon to acquire additional funds. The mortgage bears interest at 15 700,000 775,000 12 two-year term. In July 2020, the Company executed a mortgage payable on property located in Oregon to acquire additional funds. The mortgage bears interest at 14 July 31, 2023 200,000 In April 2018, the Company received a 37.5 1.275 600,000 675,000 300,000 300,000 300,000 14 4,667 400,000 The following is a table of the 5-year runoff of our long-term debt as of September 30: Schedule of Maturities of Long Term Debt 2023 $ 1,000 2024 775 2025 450 2026 - 2027 - Thereafter - Total long-term debt 2,225 Less current portion of long-term debt: (1,000 ) Long term debt $ 1,225 Finance liability In November 2020, the Company executed a mortgage payable on property located in Mulino, Oregon to acquire additional funds. The mortgage bears interest at 15 13,750 1,094,989 29,167 2 1.8

Convertible debt

Convertible debt	12 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Convertible debt	15. Convertible debt Canaccord On December 27, 2018, the Company entered into an Agency Agreement (the “Agency Agreement”) for a private offering of up to 10,000 10,000,000 In December 2018 and January 2019, the Company issued 3,121 1,000 3.1 2.3 52,430 On March 14, 2019, the Company issued 962 1,000 1.0 0.7 5,600 The total aggregate proceeds of the Offering totaled $ 4.1 3.1 Each CD Special Warrant will be exchanged (with no further action on the part of the holder thereof and for no further consideration) for one convertible debenture unit of the Company (a “Convertible Debenture Unit”), on the earlier of: (i) the third business day after the date on which both (A) a receipt (the “Receipt”) for a (final) document (the “Qualification Document”) qualifying the distribution of the Convertible Debentures (as defined below) and Warrants (as defined below) issuable upon exercise of the CD Special Warrants has been issued by the applicable securities regulatory authorities in the Canadian jurisdictions in which purchasers of the CD Special Warrants are resident (the “Canadian Jurisdictions”), and (B) a registration statement (the “Registration Statement”) registering the resale of the common shares underlying the Convertible Debentures and Warrants has been declared effective by the U.S. Securities and Exchange Commission (the “Registration”); and (ii) the date that is six months following the closing of the Offering. The Company has also provided certain registration rights to purchasers of the CD Special Warrants. The CD Special Warrants were exchanged for Convertible Debenture Units after six months as U.S. and Canadian registrations were not effective at that time. Each Convertible Debenture Unit is comprised of CDN $ 1,000 8.0 3.90 The Company has agreed to use its best efforts to obtain the Receipt and Registration within six months following the closing of the Offering. If the Receipt and Registration have not been obtained on or before 5:00 p.m. (PST) on the date that is 120 days following the closing of the Offering, each unexercised CD Special Warrant will thereafter entitle the holder thereof to receive, upon the exercise thereof and at no additional cost, 1.05 Convertible Debenture Units per CD Special Warrant (instead of 1.0 Convertible Debenture Unit per CD Special Warrant). Until the Receipt and Registration have been obtained, securities issued in connection with the Offering (including any underlying securities issued upon conversion or exercise thereof) will be subject to a six (6)-month hold period from the date of issue. Since the CD Special Warrants were exchanged for Convertible Debenture Units after six (6) months as U.S. and Canadian registrations were not effective at that time, the holders received 1.05 Convertible Debenture Units per CD Special Warrant. The brokered portion of the Offering (CDN $ 2.5 1.9 7.0 7.0 1,000 157,290 50,000 50,000 3.00 20,000 181,365 0.32 The issuance of the securities was made in reliance on the exemption provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), for the offer and sale of securities not involving a public offering, Regulation D promulgated under the Securities Act, Regulation S, in Canada to “accredited investors” within the meaning of National Instrument 45106 and other exempt purchasers in each province of Canada, except Quebec, and/or outside Canada and the United States on a basis which does not require the qualification or registration. The securities being offered have not been registered under the Securities Act and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from the registration requirements. The Convertible Debenture features contain the following embedded derivatives: ● Conversion Option - The Convertible Debentures provide the holder the right to convert all or any portion of the outstanding principal into common shares of the Company at a conversion price of C$ 3.00 333.33 1,000 ● Contingent Put - Upon an Event of Default, the Convertible Debentures settle for cash at the outstanding principal and interest amount (at discretion of the Indenture Trustee or upon request of Holders of 25 ● Contingent Put - Upon a Change in Control, the Convertible Debentures settle for cash at the outstanding amount and principal and interest * 105 The conversion option, the contingent put feature upon an Event of Default, and the contingent put feature upon a Change in Control should be bifurcated and recognized collectively as a compound embedded derivative at fair value at inception and at each quarterly reporting period. A five percent penalty assessed for failure to timely file a registration statement to register the stock underlying the CD special warrants. The Company valued the warrants granted using the Black-Scholes pricing model and determined that the value at grant date was approximately $ 424,000 Schedule of Assumptions Used for Valuation of Warrants Fair value of underlying common shares $ 1.78 2.10 Exercise price (converted to USD) $ 2.93 Dividend yield - Historical volatility 85 % Risk free interest rate 1.4 1.9 % The warrants are not indexed to the Company’s own stock under ASC 815, Derivatives and Hedging. As such, the warrants do not meet the scope exception in ASC 815-10-15-74(a) to derivative accounting and therefore were accounted for as a liability in accordance with the guidance in ASC 815. The warrant liability was recorded at the date of grant at fair value with subsequent changes in fair value recognized in earnings each reporting period. In April 2020, the Company received approval of the holders Warrant holders of the warrants and the holders debenture holders of the Convertible Debentures to reprice the convertible securities issued in connection with the Company’s special warrant financing, which closed on December 27, 2018, and June 14, 2019. The share purchase warrants of the Company issued in connection with the financing will be repriced to C$ 1.50 per Common Share and the convertible debentures of the Company issued in connection with the financing will be repriced to C$ 1.15 per common share. Additionally, the Debenture holders have approved the following amendments to the terms of the convertible debentures: (i) an extension to the maturity date of the convertible debentures to three years from the date of issuance; and (ii) an amendment to permit the Company to force the conversion of the principal amount of the then outstanding convertible debentures and any accrued and unpaid interest thereof at the new conversion price on not less than June days’ prior written notice if the closing trading price of the shares of common stock of the Company’s common shares exceeds C$ 1.90 for a period of 10 consecutive trading days on the CSE. The Warrant holders have also approved the inclusion of an early acceleration feature in accordance with the policies of the Canadian Securities Exchange, permitting the Company to accelerate the expiry date of the warrants should the closing trading price of the Common Shares exceed C$ 1.87 for a period of 10 consecutive trading days on the CSE. In June 2022, the Company received approval of the holders Warrant holders of the warrants and the holders debenture holders of the Convertible Debentures to reprice the convertible securities issued in connection with the Company’s special warrant financing, which initially closed on December 27, 2018, and June 14, 2019. The share purchase warrants of the Company issued in connection with the financing will be repriced to C$ 0.20 0.10 0.80 5 1,000 1.2 803 1.5 2.9 1.1 0 The table below shows the warrant liability and embedded derivative liability recorded in connection with the Canaccord convertible notes and the subsequent fair value measurement for the period ended September 30, 2022, in USD, ( in thousands Schedule of Warrant Liability and Embedded Derivative Liability Warrant Liability Derivative Liability Balance as of September 30, 2021 $ - $ - Modification of debentures - 339 Change in fair value - 31 Balance as of September 30, 2022 $ - $ 370

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	16. Fair Value Measurements In accordance with ASC 820 (Fair Value Measurements and Disclosures), the Company uses various inputs to measure the outstanding warrants and certain embedded conversion feature associated with convertible debt on a recurring basis to determine the fair value of the liability. ASC 820 also establishes a hierarchy categorizing inputs into three levels used to measure and disclose fair value. The hierarchy gives the highest priority to quoted prices available in active markets and the lowest priority to unobservable inputs. An explanation of each level in the hierarchy is described below: Level 1 – Unadjusted quoted prices in active markets for identical instruments that are accessible by the Company on the measurement date Level 2 – Quoted prices in markets that are not active or inputs which are either directly or indirectly observable Level 3 – Unobservable inputs for the instrument requiring the development of assumptions by the Company The following table classifies the Company’s liabilities measured at fair value on a recurring basis into the fair value hierarchy as of September 30, 2021 (in thousands): Schedule of Liabilities Measured at Fair Value on a Recurring Basis Fair value measured at September 30, 2022 Quoted prices Significant other Significant in active observable unobservable inputs Fair value (Level 1) (Level 2) (Level 3) Warrant liability $ 55 $ - $ - $ 55 Embedded derivative liability 370 - - 370 Total fair value $ 425 $ - $ - $ 425 There were no transfers between Level 1, 2 or 3 during the year ended September 30, 2022. The following table presents changes in Level 3 liabilities measured at fair value for the year ended September 30, 2022. Both observable and unobservable inputs were used to determine the fair value of positions that the Company has classified within the Level 3 category. Unrealized gains and losses associated with liabilities within the Level 3 category include changes in fair value that were attributable to both observable (e.g., changes in market interest rates) and unobservable (e.g., changes in unobservable long- dated volatilities) inputs (in thousands). Schedule of Level 3 Liabilities Measured at Fair Value Embedded Warrant Liability Derivative Liability Total Balance – September 30, 2020 $ 257 $ 592 $ 849 Warrants granted for stock-based compensation 59 - 59 Warrants issued pursuant to acquisition (see Note 9) 9,000 - 9,000 Issuance of convertible notes (66 ) (15 ) (81 ) Change in fair value (2,401 ) (577 ) (2,978 ) Cancellation of warrants pursuant to settlement agreement (4,572 ) - (4,572 ) Balance - September 30, 2021 $ 2,277 $ - $ 2,277 Warrants granted 105 - 105 Modification of debentures - 339 339 Change in fair value (2,327 ) 31 (2,296 ) Balance - September 30, 2022 $ 55 $ 370 $ 425 A summary of the weighted average (in aggregate) significant unobservable inputs (Level 3 inputs) used in measuring the Company’s warrant liabilities and embedded conversion feature that are categorized within Level 3 of the fair value hierarchy as of September 30, 2022, and 2021 is as follows: Summary of Weighted Average Significant Unobservable Inputs Warrant Liability As of September 30, As of September 30, 2022 2021 Strike price $ 0.49 $ 0.48 Contractual term (years) 1.43 2.57 Volatility (annual) 100 % 74 % Risk-free rate 4.1 % 1.0 % Dividend yield (per share) 0 % 0 % Embedded Derivative Liability As of September 30, As of September 30, 2022 2021 Strike price $ 0.10 $ 0.90 Contractual term (years) 2.8 0.8 Volatility (annual) 141 % 55 % Risk-free rate 4.00 % 0.08 % Dividend yield (per share) 0.00 % 0.00 % Credit spread 14 16 % 14 16 % The Company used a lattice based trinomial model developed by Tsiveriotis, K. and Fernades in which the three lattices incorporate (1) the Company’s underlying common stock price; (2) the value of the debt components of the convertible notes; and (3) the value of the equity component of the convertible notes. The main drivers of sensitivity for the model are volatility and the credit spread. The model used will vary by approximately 1.5 4 1 1

Income Taxes

Income Taxes	12 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	17. Income Taxes The income tax expense (benefit) consisted of the following for the fiscal year ended September 30, 2022 and 2021: Schedule of Income Tax Expenses (Benefit) September 30, September 30, 2022 2021 Total current $ - $ - Total deferred - - Income tax expense (benefit) $ - $ - Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The following is a reconciliation of the expected statutory federal income tax provision to the actual income tax benefit for the fiscal year ended September 30, 2022 and 2021: Schedule of Reconciliation of Statutory Federal Income Tax Provision to Actual Income Tax Benefit September 30, September 30, 2022 2021 Federal statutory rate $ (4,382 ) $ (16,152 ) Permanent timing differences 3,272 12,165 Other (58 ) - Change in valuation allowance 1,168 3,987 Income tax expense $ - $ - For the years ended September 30, 2022 and 2021, the expected tax benefit, temporary timing differences and long-term timing differences are calculated at the 25 Significant components of the Company’s deferred tax assets and liabilities were as follows for the fiscal year ended September 30, 2022 and 2021: Schedule of Deferred Tax Assets and Liabilities September 30, September 30, 2022 2021 Deferred tax assets: Net operating loss carryforwards $ 10,110 $ 8,454 Equity based compensation 3,045 3,192 Impairment of investments and other property 2,011 2,362 Total deferred tax assets 15,166 14,008 Deferred tax liabilities Depreciation 39 49 Total deferred tax liabilities 39 49 Net deferred tax assets 15,127 13,959 Less valuation allowance (15,127 ) (13,959 ) Net deferred tax assets (liabilities) $ - $ - At September 30, 2022, the Company had net operating loss carryforwards for federal and state income tax purposes of approximately $ 40 expire beginning in 2038. During the fiscal year ended September 30, 2022 and 2021 the Company recognized no amounts related to tax interest or penalties related to uncertain tax positions. The Company is subject to taxation in the United States and various state jurisdictions. The Company currently has no years under examination by any jurisdiction.

Shareholders_ Equity

Shareholders’ Equity	12 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Shareholders’ Equity	18. Shareholders’ Equity In 2016, the Company adopted a plan to allow the Company to compensate prospective and current employees, directors, and consultants through the issuance of equity instruments of the Company. The plan has an effective life of 10 years. The plan is administered by the board of directors of the Company until such time as the board transfers responsibility to a committee of the board. The plan is limited to issuing common shares of the Company up to 15% of the total shares then outstanding. No limitations exist on any other instruments issuable under the plan. In the event of a change in control of the Company, all unvested instruments issued under the plan become immediately vested. Pursuant to the shareholders meeting on June 25, 2021, the Company has amended its certificate of incorporation to increase the number of authorized Company Common Shares from 300,000,000 750,000,000 Preferred shares The Company had two series of preferred shares designated with no preferred shares issued and outstanding as of September 30, 2022, and September 30, 2021. Common shares During the year ended September 30, 2022, the Company issued 3,223,611 285,000 During the year ended September 30, 2022, the Company issued 130,000 30,000 During the year ended September 30, 2022, the Company issued 3,137,500 313,000 During the year ended September 30, 2022, the Company converted $13,000 of principal balance related to convertible debt in exchange for 289,750 1,751,186 121,000 During the year ended September 30, 2022, the Company received 11,506,700 During the year ended September 30, 2021, the Company issued 3,914,509 1,675,000 During the year ended September 30, 2021, the Company issued 4,790,070 2,032,000 0.29 0.51 During the year ended September 30, 2021, the Company sold 1,465,117 630,000 During the year ended September 30, 2021, the Company cancelled 525,400 During the year ended September 30, 2021, the Company cancelled 58,140 During the year ended September 30, 2021, the Company converted $ 309,121 553,417 293,700 117,480 During the year ended September 30, 2021, as part of the Agreement and Plan of Merger with Driven Deliveries the Company issued 101,968,944 During the year ended September 30, 2021, the Company issued 300,000 210,000 During the year ended September 30, 2021, the Company converted $ 4,913,000 9,480,259 During the year ended September 30, 2021, the Company issued 500,000 5,439,855 During the year ended September 30, 2021, the Company raised $ 4,892,000 5,322,136 During the year ended September 30, 2021, the Company issued 10,000 During the year ended September 30, 2021, the Company issued 90,909 40,000 During the year ended September 30, 2021, the Company cancelled 694,233 During the year ended September 30, 2021, the Company issued 19,276,340 7,919 During the year ended September 30, 2021, the Company issued 8,209,178 2,380,661 During the year ended September 30, 2021, the Company raised $ 2,869,889 6,833,069

Stock Based Compensation

Stock Based Compensation	12 Months Ended
	Sep. 30, 2022
Compensation Related Costs [Abstract]
Stock Based Compensation	19. Stock Based Compensation Stock Options The fair value of the Company’s common stock was based upon the publicly quoted price on the date that the final approval of the awards was obtained. The Company does not expect to pay dividends in the foreseeable future so therefore the expected dividend yield is 0 The fair value of options granted during the years ended September 30, 2022, and 2021 were estimated using the following weighted-average assumptions: Options: Schedule of Fair Value of Options Granted For the Years Ended September 30, 2022 2021 Exercise price $ 0.07 $ 0.28 Expected term (years) 2.52 4.39 Expected stock price volatility 124 % 74 % Risk-free rate of interest 2.42 % 0.98 % Expected dividend rate 0 % 0 % A summary of option activity under the Company’s stock option plan for the year ended September 30, 2022 is presented below: Schedule of Stock Option Activity Number of Shares Weighted Average Exercise Price Total Intrinsic Value Weighted Average Remaining Contractual Life (in years) Outstanding as of October 1, 2020 5,572,916 $ 1.77 $ - 2.21 Granted 1,125,000 0.28 $ 54 4.39 Outstanding as of September 30, 2021 6,697,916 $ 1.07 $ - 2.09 Granted 1,500,000 0.07 $ - 3.00 Expired/cancelled (2,242,231 ) (0.67 ) $ - - Outstanding as of September 30, 2022 5,955,685 $ 1.07 $ - 2.90 Options vested and exercisable 5,518,185 $ 0.03 $ - 2.60 Estimated future stock-based compensation expense relating to unvested stock options was nominal as of September 30, 2022, and 2021. Weighted average remaining contractual life of the options is 2.60 Restricted Stock A summary of employee restricted stock activity for years ended September 30, 2022 and 2021 are presented below: Schedule of Employee Restricted Stock Activity Number of Shares Weighted Average Exercise Price Outstanding as of October 1, 2020 2,471,317 1.57 Granted (1) 3,914,509 0.96 Outstanding as of September 30, 2021 6,385,826 0.93 Granted 2,637,500 0.11 Outstanding as of September 30, 2022 9,023,326 $ 0.69 A summary of non-employee restricted stock activity under the Company’s for years ended September 30, 2022 and 2021 are presented below: Schedule of Non Employee Restricted Stock Activity Number of Shares Weighted Average Exercise Price Outstanding as of September 30, 2020 3,859,178 1.72 Granted 5,058,370 0.58 Outstanding as of September 30, 2021 8,917,548 0.99 Granted 630,000 0.67 Outstanding as of September 30, 2022 9,547,548 $ 0.97 Warrants A summary of the status of the Company’s outstanding warrants as of September 30, 2022 and 2021 and changes during the year then ended are presented below: Schedule of Warrants Outstanding Number of Warrants Weighted Average Exercise Price Remaining Contractual Term Outstanding as of September 30, 2020 5,114,733 $ 2.13 1 Warrants granted – equity 32,666,266 0.53 2 Warrants expired – equity (114,300 ) 2.50 0 Warrants granted – liability 30,299,134 0.45 3.04 Warrants expired – liability (5,000,000 ) 0.20 1.51 Outstanding as of September 30, 2021 62,965,833 0.47 1.23 Warrants exercised – equity (1,000,000 ) 0.04 - Warrants granted – equity 4,173,612 0.10 2.00 Warrants expired – equity (972,117 ) 0.10 - Warrants granted – liability 615,731 0.12 2.00 Outstanding as of September 30, 2022 65,783,059 0.49 1.43 Stock-based Compensation Expense Stock-based compensation expense for the years ended September 30, 2022, and 2021 was comprised of the following (in thousands): Schedule of Stock-based Compensation Expenses 2022 2021 Years Ended September 30, 2022 2021 Restricted stock awards $ 296 $ 1,935 Stock options 454 279 Warrants 263 59 Accrued stock compensation - - Total stock-based compensation $ 1,013 $ 2,273

Commitments and contingencies

Commitments and contingencies	12 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies	20. Commitments and contingencies As noted earlier in Note 1, the Company, engages in a business that constitutes an illegal act under the laws of the United States Federal Government. This raises several possible issues which may impact the Company’s overall operations, not the least of which are related to traditional banking and other key operational risks. Since cannabis remains illegal on the federal level, and most traditional banks are federally insured, those financial institutions will not service cannabis businesses. In states where medical or recreational marijuana is legal, dispensary owners, manufacturers, and anybody who “touches the plant,” continue to face a host of operational hurdles. While local, state-chartered banks and credit unions now accept cannabis commerce, there remains a reluctance by traditional banks to do business with them. Aside from a huge inconvenience and the need to find creative ways to manage financial flow, payroll logistics, and payment of taxes, his also poses tremendous risks to controls as a result of operating a lucrative business in cash. This lack of access to traditional banking may inhibit industry growth. For the year ended September 30, 2022, the Company’s has accounts with a Florida bank and several credit unions located in Washington and California. Despite the uncertainties surrounding the Federal government’s position on legalized marijuana, the Company does not believe these risks will have a substantive impact on its planned operations in the near term. The Company executed an Agency Agreement and in consideration of the services rendered by the Agent and in connection with the Offering, the Company has agreed to pay the Agent, on the Closing Date a commission equal to 7 Agent’s Commission President’s ‎List Broker Warrants Broker Share 7 3.5 0.55 100,000 Corporate Finance Fee 50,000 50,000 90,909 Corporate Finance Fee Shares 350,000 Over-Allotment Option 15 2,590,909 Additional Units 9,200,000 644,000 8,556,000 10,925,000 764,750 10,160,250 16,926,019 1,471,291 0.55 10,309,210 809,210.05 April 23, 2023 0.68 972,092 0.43 420,000 Legal Proceedings D.H. Flamingo, Inc. v. Department of Taxation, et. al. On February 27, 2020, a subsidiary of the Company (YMY Ventures, LLC) was served with a Summons and Second Amended Complaint in a matter pending in the District Court of Clark County Nevada (Case # A-19-787004-B) which is styled “D.H. Flamingo, Inc. v. Department of Taxation, et. al. Chris Hass, et al. vs Brian Hayek, et al. Plaintiffs filed their initial complaint in the instant action on May 22, 2020. Plaintiffs filed the operative first amended complaint on August 18, 2020. On March 28, 2022, Plaintiffs obtained a stipulated judgment in this action in the amount of $ 349,876.69 Under California law, Stem, as Driven Deliveries’ prior parent company was legally required to assume Driven Deliveries’ debt to Plaintiffs. If a domestic corporation owns all the outstanding shares, or owns less than all the outstanding shares but at least 90 percent of the outstanding shares of each class, of a corporation or corporations, domestic or foreign, the merger of the subsidiary corporation or corporations into the parent corporation or the merger into the subsidiary corporation of the parent corporation and any other subsidiary corporation or corporations, may be effected by a resolution or plan of merger adopted and approved by the board of the parent corporation and the filing of a certificate of ownership as provided in subdivision . The resolution or plan of merger shall provide for the merger and shall provide that the surviving corporation assumes all the liabilities of each disappearing corporation and shall include any other provisions required by this section. Stem’s S-4 Statement to the SEC states, “Driven is surviving the merger as a wholly owned subsidiary of Stem (the ‘Merger’). Stem, together with Driven following the Merger, is referred to herein as the combined company. Following the completion of the Merger, Stem will also assume Driven’s outstanding net indebtedness.” Plaintiffs argue that while the merger with Stem was pending, Driven and Stem’s COO, Brian Hayek agreed to be bound by California law in executing the Settlement Agreement. Accordingly, applying California law, Stem assumed Dirven’s liability to Plaintiffs. Accordingly, Plaintiffs have demonstrated Stem is Driven Deliveries’ successor in interest. In the interest of justice this Court grants Plaintiffs’ motion to amend judgment to add nonparty Stem Holdings Inc. as an additional defendant. Additionally, the Company is subject from time to time to litigation, claims and suits arising in the ordinary course of business.

Subsequent events

Subsequent events	12 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent events	21. Subsequent events In November 2022, the Company completed a private placement of a $ 250,000 250,000 5,000 10 0.05 In January 2023, the Company has partially converted a $ 250,000 7,352,941 50 125,000 In January 2023, the Company has executed a $ 250,000 500,000 0.01 12 0.005 In January 2023, pursuant to an Oregon Real Estate Agreement, the Company sold its ownership interest in Never Again 2, LLC. The purchase price for this land was $ 275,000

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Company’s consolidated financial statements been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All material intercompany accounts and transactions have been eliminated during the consolidation process. The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income, and expenses. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value equity instruments, valuation of its long live assets for impairment testing, valuation of intangible assets, and the valuation of inventory. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable given the circumstances that exist at the time the financial statements are prepared. Actual results may differ materially and adversely from these estimates. To the extent there are material differences between the estimates and actual results, the Company’s future results of operations will be affected.
Reclassifications	Reclassifications Certain amounts in the Company’s consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods.
Principles of Consolidation	Principles of Consolidation The Company’s policy is to consolidate all entities that it controls by ownership of a majority of the outstanding voting stock. In addition, the Company consolidates entities that meet the definition of a variable interest entity (“VIE”) for which it is the primary beneficiary. The primary beneficiary is the party who has the power to direct the activities of a VIE that most significantly impact the entity’s economic performance and who has an obligation to absorb losses of the entity or a right to receive benefits from the entity that could potentially be significant to the entity. For consolidated entities that are less than wholly owned, the third party’s holding of equity interest is presented as noncontrolling interests in the Company’s Consolidated Balance Sheets and Consolidated Statements of Changes in Stockholders’ Equity. The portion of net loss attributable to the noncontrolling interests is presented as net loss attributable to noncontrolling interests in the Company’s Consolidated Statements of Operations. The accompanying consolidated financial statements include the accounts of Stem Holdings, Inc. and its wholly owned subsidiaries, Stem Holdings Oregon, Inc., Stem Holdings IP, Inc., Opco, LLC, Stem Holdings Agri, Inc., Stem Oregon Acquisitions 2 Corp., Stem Oregon Acquisitions 3 Corp., Stem Oregon Acquisitions 4 Corp., 7LV USA Corporation, and Stem Oregon Acquisitions 1 Corp., and Driven Deliveries, Inc., which was subsequently divested. In addition, the Company has consolidated YMY Ventures, WCV, LLC and NVD RE, Inc. under the variable interest requirements.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with a maturity of three months or less at the time of purchase to be cash equivalents. Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents. The Company’s cash is primarily maintained in checking accounts. These balances may, at times, exceed the U.S. Federal Deposit Insurance Corporation insurance limits. As of September 30, 2022, and 2021, the Company had no cash equivalents or short-term investments. The Company has not experienced any losses on deposits of cash and cash equivalents.
Accounts Receivable	Accounts Receivable Accounts receivable is shown on the face of the consolidated balance sheets, net of an allowance for doubtful accounts. The Company analyzes the aging of accounts receivable, historical bad debts, customer creditworthiness and current economic trends, in determining the allowance for doubtful accounts. The Company does not accrue interest receivable on past due accounts receivable. As of September 30, 2022, and 2021 the reserve for doubtful accounts was $ 79
Inventory	Inventory Inventory is comprised of raw materials, finished goods and work-in-progress such as pre-harvested cannabis plants and by-products to be extracted. The costs of growing cannabis including but not limited to labor, utilities, nutrition, and irrigation, are capitalized into inventory until the time of harvest. The Company recorded an adjustment to reduce inventory to net realizable value of $ 88 0 Inventory is stated at the lower of cost or net realizable value, determined using weighted average cost. Cost includes expenditures directly related to manufacturing and distribution of the products. Primary costs include raw materials, packaging, direct labor, overhead, shipping and the depreciation of manufacturing equipment and production facilities determined at normal capacity. Manufacturing overhead and related expenses include salaries, wages, employee benefits, utilities, maintenance, and property taxes. Net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. At the end of each reporting period, the Company performs an assessment of inventory obsolescence to measure inventory at the lower of cost or net realizable value. Factors considered in the determination of obsolescence include slow-moving or non-marketable items.
Prepaid Expenses and Other Current Assets	Prepaid Expenses and Other Current Assets Prepaid expenses consist of various payments that the Company has made in advance for goods or services to be received in the future. These prepaid expenses include consulting, advertising, insurance, and service or other contracts requiring up-front payments.
Property and Equipment	Property and Equipment Property, equipment, and leasehold improvements are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets Expenditures for major renewals and improvements are capitalized, while minor replacements, maintenance, and repairs, which do not extend the asset lives, are charged to operations as incurred. Upon sale or disposition, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operations. The Company continually monitors events and changes in circumstances that could indicate that the carrying balances of its property, equipment and leasehold improvements may not be recoverable in accordance with the provisions of ASC 360, “Property, Plant, and Equipment.” When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. See “Note 3 – Property, Equipment and Leasehold Improvements”. Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided on a straight-line method over the estimated useful lives of the assets. The Company estimates useful lives as follows: Schedule of Estimated Useful Life of Assets Buildings 20 Leasehold improvements Shorter of term of lease or economic life of improvement Furniture and equipment 5 Signage 5 Software and related 5
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets The Company reviews the carrying value of its long-lived assets, which include property and equipment, for indicators of impairment whenever events or changes in circumstances indicate that the carrying value of an asset or asset group may not be recoverable. The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i) significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in the Company’s overall strategy with respect to the manner or use of the acquired assets or changes in the Company’s overall business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant decline in the Company’s stock price for a sustained period of time; and (vi) regulatory changes. The Company evaluates assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events. The Company does not test for impairment in the year of acquisition of properties, as long as those properties are acquired from unrelated third parties. The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts. In cases where estimated future net undiscounted cash flows are less than the carrying value, an impairment loss is recognized equal to an amount by which the carrying value exceeds the fair value of the asset or asset group. Fair value is generally determined using the assets expected future discounted cash flows or market value, if readily determinable. If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated and amortized prospectively over the newly determined remaining estimated useful lives.
Equity Method Investments	Equity Method Investments Investments in unconsolidated affiliates are accounted for under the equity method of accounting, as appropriate. The Company accounts for investments in limited partnerships or limited liability corporations, whereby the Company owns a minimum of 5.0 During the years ended September 30, 2022, and 2021, the Company recognized its share of investee losses of approximately $ 0 234 233 1 Investments were impaired by $ 795 2.2
Asset Acquisitions	Asset Acquisitions The Company has adopted ASU 2017-01, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as businesses acquisitions. As a result of adopting ASU 2017-01, acquisitions of real estate and cannabis licenses do not meet the definition of a business combination and were deemed asset acquisitions, and the Company therefore capitalized these acquisitions, including its costs associated with these acquisitions.
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill. 5.9 0 Intangible Assets 1,961 0 An intangible asset with an indefinite useful life is not amortized but assessed for impairment annually, or more frequently, when events or changes in circumstances occur indicating that it is more likely than not that the indefinite-lived asset is impaired. Impairment exists when the carrying amount exceeds its fair value. In testing for impairment, the Company has the option to first perform a qualitative assessment to determine whether it is more likely than not that an impairment exists. If it is determined that it is not more likely than not that an impairment exists, a quantitative impairment test is not necessary. If the Company concludes otherwise, it is required to perform a quantitative impairment test. To the extent an impairment loss is recognized, the loss establishes the new cost basis of the asset that is amortized over the remaining useful life of that asset, if any. Subsequent reversal of impairment losses is not permitted.
Business Combinations	Business Combinations The Company applies the provisions of ASC 805 in the accounting for acquisitions. ASC 805 requires the Company to recognize separately from goodwill the assets acquired, and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions to accurately apply preliminary value to assets acquired and liabilities assumed at the acquisition date as well as contingent consideration, where applicable, these estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments in the current period, rather than a revision to a prior period. Upon the conclusion of the measurement period or final determination of the values of the assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded in the consolidated statements of operations. Accounting for business combinations requires management to make significant estimates and assumptions, especially at the acquisition date, including estimates for intangible assets, contractual obligations assumed, restructuring liabilities, pre-acquisition contingencies, and contingent consideration, where applicable. Although the Company believes the assumptions and estimates made have been reasonable and appropriate, they are based in part on historical experience and information obtained from management of the acquired companies and are inherently uncertain. Unanticipated events and circumstances may occur that may affect the accuracy or validity of such assumptions, estimates, or actual results.
Contingent Consideration	Contingent Consideration The Company accounts for “contingent consideration” according to FASB ASC 805, “Business Combinations” (“FASB ASC 805”). Contingent consideration typically represents the acquirer’s obligation to transfer additional assets or equity interests to the former owners of the acquiree if specified future events occur or conditions are met. FASB ASC 805 requires that contingent consideration be recognized at the acquisition-date fair value as part of the consideration transferred in the transaction. FASB ASC 805 uses the fair value definition in Fair Value Measurements, which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As defined in FASB ASC 805, contingent consideration is (i) an obligation of the acquirer to transfer additional assets or equity interests to the former owners of an acquiree as part of the exchange for control of the acquiree, if specified future events occur or conditions are met or (ii) the right of the acquirer to the return of previously transferred consideration if specified conditions are met.
Warrant Liability	Warrant Liability The Company accounts for certain common stock warrants outstanding as a liability at fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s consolidated statements of operations. The fair value of the warrants issued by the Company has been estimated using a Black Scholes model.
Embedded Conversion Features	Embedded Conversion Features The Company evaluates embedded conversion features within convertible debt to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in the statement of operations. If the conversion feature does not require recognition of a bifurcated derivative, the convertible debt instrument is evaluated for consideration of any beneficial conversion feature (“BCF”) requiring separate recognition. When the Company records a BCF, the intrinsic value of the BCF is recorded as a debt discount against the face amount of the respective debt instrument (offset to additional paid-in capital) and amortized to interest expense over the life of the debt.
Income Taxes	Income Taxes The provision for income taxes is determined in accordance with ASC 740, “Income Taxes”. The Company files a consolidated United States federal income tax return. The Company provides for income taxes based on enacted tax law and statutory tax rates at which items of income and expense are expected to be settled in our income tax return. Certain items of revenue and expense are reported for Federal income tax purposes in different periods than for financial reporting purposes, thereby resulting in deferred income taxes. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company has incurred net operating losses for financial-reporting and tax-reporting purposes. As of September 30, 2022, and 2021, such net operating losses were offset entirely by a valuation allowance. The Company recognizes uncertain tax positions based on a benefit recognition model. Provided that the tax position is deemed more likely than not of being sustained, the Company recognizes the largest amount of tax benefit that is greater than 50.0% likely of being ultimately realized upon settlement. The tax position is derecognized when it is no longer more likely than not of being sustained. The Company classifies income tax related interest and penalties as interest expense and selling, general and administrative expense, respectively, on the consolidated statements of operations. In December 2017, the Tax Cuts and Jobs Act (TCJA or the Act) was enacted, which significantly changes U.S. tax law. In accordance with ASC 740, “Income Taxes”, the Company is required to account for the new requirements in the period that includes the date of enactment. The Act reduced the overall corporate income tax rate to 21.0
Revenue Recognition	Revenue Recognition The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of Accounting Standards Codification (ASC) Topic 606, Revenue from Contracts with Customers (Topic 606), the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of Topic 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Revenue for the Company’s product sales has not been adjusted for the effects of a financing component as the Company expects, at contract inception, that the period between when the Company’s transfers control of the product and when the Company receives payment will be one year or less. Product shipping and handling costs are included in cost of product sales. The following policies reflect specific criteria for the various revenue streams of the Company: Cannabis Dispensary, Cultivation and Production Revenue is recognized upon transfer of retail merchandise to the customer upon sale transaction, at which time its performance obligation is complete. Revenue is recognized upon delivery of product to the wholesale customer, at which time the Company’s performance obligation is complete. Terms are generally between cash on delivery to 30 days for the Company’s wholesale customers. The Company’s sales environment is somewhat unique, in that once the product is sold to the customer (retail) or delivered (wholesale) there are essentially no returns allowed or warranty available to the customer under the various state laws. Delivery 1) Identify the contract with a customer The Company sells retail products directly to customers. In these sales there is no formal contract with the customer. These sales have commercial substance and there are no issues with collectability as the customer pays the cost of the goods at the time of purchase or delivery. 2) Identify the performance obligations in the contract The Company sells its products directly to consumers. In this case these sales represent a performance obligation with the sales and any necessary deliveries of those products. 3) Determine the transaction price The sales that are done directly to the customer have no variable consideration or financing component. The transaction price is the cost that those goods are being sold for plus any additional delivery costs. 4) Allocate the transaction price to performance obligations in the contract For the goods that the Company sells directly to customers, the transaction price is allocated between the cost of the goods and any delivery fees that may be incurred to deliver to the customer. 5) Recognize revenue when or as the Company satisfies a performance obligation For the sales of the Company’s own goods the performance obligation is complete once the customer has received the product.
Leases	Leases On October 1, 2020, the Company adopted ASC 842 and elected to apply the new standard at the adoption date and recognize a cumulative effect as an adjustment to retained earnings. Upon calculation the effect on retained earnings was immaterial and no adjustment was deemed necessary. Leases with an initial term of twelve months or less are not recorded on the balance sheet. For lease agreements entered into or reassessed after the adoption of Topic 842, we combine the lease and non-lease components in determining the lease liabilities and right of use (“ROU”) assets. Our lease agreements generally do not provide an implicit borrowing rate; therefore, an internal incremental borrowing rate is determined based on information available at lease commencement date for purposes of determining the present value of lease payments. We used the incremental borrowing rate on September 30, 2022, for all leases that commenced prior to that date. In determining this rate, which is used to determine the present value of future lease payments, we estimate the rate of interest we would pay on a collateralized basis, with similar payment terms as the lease and in a similar economic environment. Under Topic 842, operating lease expense is generally recognized evenly over the term of the lease. Lease costs were $ 1,224 599 0 17 4 177 Lease Costs Schedule of Lease Costs Year Ended September 30, 2022 Components of total lease costs: Operating lease expense $ 1,224 Total lease costs $ 1,224 Lease positions as of September 30, 2022 ROU lease assets and lease liabilities for our operating leases were recorded in the consolidated condensed balance sheet as follows: Schedule of Right-of-Use Assets and Lease Liabilities September 30, 2022 Assets Right of use asset $ 6,874 Total assets $ 6,874 Liabilities Operating lease liabilities – short term $ 580 Operating lease liabilities – long term 6,476 Total lease liability $ 7,056 Lease Terms and Discount Rate Schedule of Lease Terms and Discount Rate Weighted average remaining lease term (in years) – operating lease 12.23 Weighted average discount rate – operating lease 11.04 % Cash Flows Schedule of Cash Flow Related to Lease Year Ended September 30, 2022 Cash paid for amounts included in the measurement of lease liabilities: ROU amortization $ 1,224 Cash paydowns of operating liability $ (1,224 ) Supplemental non-cash amounts of lease liabilities arising from obtaining: ROU asset $ 6,874 Lease Liability $ 7,056 The future minimum lease payments under the leases are as follows: Schedule of Future Minimum Lease Payments 2022 2023 $ 1,337 2024 1,147 2025 1,053 2026 1,033 2027 825 Thereafter 8,345 Total future minimum lease payments 13,740 Less: Lease imputed interest (6,684 ) Total $ 7,056
Disaggregation of Revenue	Disaggregation of Revenue In the year ended September 30, 2022, and 2021, revenue reported was primarily from the sale of cannabis and related products accounted for under ASC 606. The following table illustrates our revenue by type related to the years ended September 30, 2022, and 2021: Schedule of Disaggregation of Revenue 2022 2021 September 30, 2022 2021 Revenue Wholesale $ 4,306 $ 5,270 Retail 14,867 18,432 Rental - 17 Other 118 692 Total revenue 19,291 24,411 Discounts and returns (2,728 ) (3,474 ) Net Revenue $ 16,563 $ 20,937
Geographical Concentrations	Geographical Concentrations As of September 30, 2022, the Company is primarily engaged in the production and sale of cannabis, which is only legal for recreational use in 19 states and D.C., with lesser legalization, such as for medical use in an additional 21 states and D.C., as of the time of these consolidated financial statements. In addition, the United States Congress has passed legislation, specifically the Agriculture Improvement Act of 2018 (also known as the “Farm Bill”) that has removed production and consumption of hemp and associated products from Schedule 1 of the Controlled Substances Act.
Cost of Goods Sold	Cost of Goods Sold Cost of sales represents costs directly related to manufacturing and distribution of the Company’s products. Primary costs include raw materials, packaging, direct labor, overhead, shipping and handling and the depreciation of manufacturing equipment and production facilities. Manufacturing overhead and related expenses include salaries, wages, employee benefits, utilities, maintenance, and property taxes. The Company recognizes the cost of sales as the associated revenues are recognized.
Fair Value of Financial Instruments	Fair Value of Financial Instruments As defined in the authoritative guidance, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To estimate fair value, the Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated or generally unobservable. The authoritative guidance establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (“Level 1” measurements) and the lowest priority to unobservable inputs (“Level 3” measurements). The three levels of the fair value hierarchy are as follows: Level 1 — Observable inputs such as quoted prices in active markets at the measurement date for identical, unrestricted assets or liabilities. Level 2 — Other inputs that are observable, directly, or indirectly, such as quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability. Level 3 — Unobservable inputs for which there is little or no market data and which the Company makes its own assumptions about how market participants would price the assets and liabilities. In instances in which multiple levels of inputs are used to measure fair value, hierarchy classification is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.
Stock-based Compensation	Stock-based Compensation The Company accounts for share-based payment awards exchanged for services at the estimated grant date fair value of the award. Stock options issued under the Company’s long-term incentive plans are granted with an exercise price equal to no less than the market price of the Company’s stock at the date of grant and expire up to ten years from the date of grant. These options generally vest on the grant date or over a one-year period. The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model and the assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. Expected Term Expected Volatility Risk-Free Interest Rate Expected Dividend Effective January 1, 2017, the Company elected to account for forfeited awards as they occur, as permitted by Accounting Standards Update (“ASU”) 2016-09. Ultimately, the actual expenses recognized over the vesting period will be for those shares that vested. Prior to making this election, the Company estimated a forfeiture rate for awards at 0%, as the Company did not have a significant history of forfeitures.
Earnings (Loss) per Share	Earnings (Loss) per Share ASC 260, Earnings Per Share, requires dual presentation of basic and diluted earnings per share (“EPS”) with a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. Basic EPS excludes dilution. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the entity. Basic net loss per share of common stock excludes dilution and is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share of common stock reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the entity unless inclusion of such shares would be anti-dilutive. Since the Company has only incurred losses, basic and diluted net loss per share is the same. Securities that could potentially dilute loss per share in the future that were not included in the computation of diluted loss per share as of September 30, 2022, and 2021 are as follows: Schedule of Computation of Diluted Loss Potentially dilutive share-based instruments: September 30, September 30, 2022 2021 Convertible notes 34,736,220 3,696,311 Options to purchase common stock 5,518,185 7,140,447 Unvested restricted stock awards - - Warrants to purchase common stock 65,783,059 62,965,833 Anti-dilutive Securities 106,037,464 73,802,591
Advertising Costs	Advertising Costs The Company follows the policy of charging the cost of advertising to expense as incurred. Advertising expense was $ 266 368
Related parties	Related parties Parties are related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal with if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.
Segment reporting	Segment reporting Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision–making group in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision–maker is its chief executive officer. The Company currently operates in one
Recent Accounting Guidance	Recent Accounting Guidance In January 2017, the FASB issued ASU 2017-04, Intangibles—Goodwill and Other (Topic 350)—Simplifying the Test for Goodwill Impairment. ASU 2017-04 simplifies the accounting for goodwill impairments by eliminating the requirement to compare the implied fair value of goodwill with its carrying amount as part of step two of the goodwill impairment test referenced in Accounting Standards Codification (“ASC”) 350, Intangibles - Goodwill and Other (“ASC 350”). As a result, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. However, the impairment loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. ASU 2017-04 is effective for annual reporting periods beginning after December 15, 2019. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements and related disclosures. In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”). ASU 2018-13 removes, modifies and adds certain disclosure requirements in Topic 820 “Fair Value Measurement”. ASU 2018-13 eliminates certain disclosures related to transfers and the valuations process, modifies disclosures for investments that are valued based on net asset value, clarifies the measurement uncertainty disclosure, and requires additional disclosures for Level 3 fair value measurements. ASU 2018-13 is effective for the Company for annual and interim reporting periods beginning January 1, 2020. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements and related disclosures. In February 2016, the FASB issued ASU No. 2016-02, Leases. The standard amends the existing lease accounting guidance and requires lessees to recognize a lease liability and a right-of-use asset for all leases (except for short-term leases that have a duration of one year or less) on their balance sheets. Lessees will continue to recognize lease expense in a manner similar to current accounting. For lessors, accounting for leases under the new guidance is substantially the same as in prior periods but eliminates current real estate-specific provisions and changes the treatment of initial direct costs. Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparable period presented, with an option to elect certain transition relief. Full retrospective application is prohibited. The standard was adopted as of October 1, 2020. As of September 30, 2022, the Company recognized additional operating liabilities of approximately $ 7.1 6.9 In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 provides guidance for recognizing credit losses on financial instruments based on an estimate of current expected credit losses model. The amendments are effective for fiscal years beginning after December 15, 2019. Recently, the FASB issued the final ASU to delay adoption for smaller reporting companies to calendar year 2023. The Company is currently assessing the impact of the adoption of this ASU on its financial statements. In January 2020, the FASB issued ASU 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivative and Hedging (Topic 815), which clarifies the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. The guidance clarifies how to account for the transition into and out of the equity method of accounting when considering observable transactions under the measurement alternative. The ASU is effective for annual reporting periods beginning after December 15, 2020, including interim reporting periods within those annual periods, with early adoption permitted. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements and related disclosures. In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This ASU amends the guidance on convertible instruments and the derivatives scope exception for contracts in an entity’s own equity, and also improves and amends the related EPS guidance for both Subtopics. The ASU will be effective for annual reporting periods beginning after December 15, 2021 and interim periods within those annual periods and early adoption is permitted. We are currently evaluating the impact of the new guidance on our consolidated financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Schedule of Estimated Useful Life of Assets	Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided on a straight-line method over the estimated useful lives of the assets. The Company estimates useful lives as follows: Schedule of Estimated Useful Life of Assets Buildings 20 Leasehold improvements Shorter of term of lease or economic life of improvement Furniture and equipment 5 Signage 5 Software and related 5
Schedule of Lease Costs	Lease Costs Schedule of Lease Costs Year Ended September 30, 2022 Components of total lease costs: Operating lease expense $ 1,224 Total lease costs $ 1,224
Schedule of Right-of-Use Assets and Lease Liabilities	ROU lease assets and lease liabilities for our operating leases were recorded in the consolidated condensed balance sheet as follows: Schedule of Right-of-Use Assets and Lease Liabilities September 30, 2022 Assets Right of use asset $ 6,874 Total assets $ 6,874 Liabilities Operating lease liabilities – short term $ 580 Operating lease liabilities – long term 6,476 Total lease liability $ 7,056
Schedule of Lease Terms and Discount Rate	Lease Terms and Discount Rate Schedule of Lease Terms and Discount Rate Weighted average remaining lease term (in years) – operating lease 12.23 Weighted average discount rate – operating lease 11.04 %
Schedule of Cash Flow Related to Lease	Cash Flows Schedule of Cash Flow Related to Lease Year Ended September 30, 2022 Cash paid for amounts included in the measurement of lease liabilities: ROU amortization $ 1,224 Cash paydowns of operating liability $ (1,224 ) Supplemental non-cash amounts of lease liabilities arising from obtaining: ROU asset $ 6,874 Lease Liability $ 7,056
Schedule of Future Minimum Lease Payments	The future minimum lease payments under the leases are as follows: Schedule of Future Minimum Lease Payments 2022 2023 $ 1,337 2024 1,147 2025 1,053 2026 1,033 2027 825 Thereafter 8,345 Total future minimum lease payments 13,740 Less: Lease imputed interest (6,684 ) Total $ 7,056
Schedule of Disaggregation of Revenue	The following table illustrates our revenue by type related to the years ended September 30, 2022, and 2021: Schedule of Disaggregation of Revenue 2022 2021 September 30, 2022 2021 Revenue Wholesale $ 4,306 $ 5,270 Retail 14,867 18,432 Rental - 17 Other 118 692 Total revenue 19,291 24,411 Discounts and returns (2,728 ) (3,474 ) Net Revenue $ 16,563 $ 20,937
Schedule of Computation of Diluted Loss	Schedule of Computation of Diluted Loss Potentially dilutive share-based instruments: September 30, September 30, 2022 2021 Convertible notes 34,736,220 3,696,311 Options to purchase common stock 5,518,185 7,140,447 Unvested restricted stock awards - - Warrants to purchase common stock 65,783,059 62,965,833 Anti-dilutive Securities 106,037,464 73,802,591

Discontinued Operations, Asse_2

Discontinued Operations, Assets and Liabilities Held for Sale (Tables)	12 Months Ended
	Sep. 30, 2022
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Discontinued Operations of Assets and Liabilities	The following table presents the assets and liabilities associated with the divestiture of Driven Deliveries; Inc. as follows (in thousands): Schedule of Discontinued Operations of Assets and Liabilities December 15, September 30, 2021 2021 ASSETS Current assets Cash and cash equivalents $ 47 $ 106 Inventory 509 382 Prepaid expenses and other current assets 242 887 Total current assets 798 1,375 Property and equipment, net 4 12 Right of use asset 327 328 Intangible assets, net 7,049 7,609 Total assets $ 8,178 $ 9,324 LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities Accounts payable and accrued expenses 7,551 5,967 Short term notes and advances 3 7 Settlement payable - 92 Acquisition notes payable - 409 Lease liability 218 218 Total current liabilities 7,772 6,693 Lease liability - long term 108 108 Total liabilities $ 7,880 $ 6,801 The total assets and total liabilities in the above table for the year ended September 30, 2021, are presented in the balance sheet as of September 30, 2022, as Assets held for sale and Liabilities held for sale. The following table presents the operating results related to the divestiture of Driven Deliveries; Inc. (in thousands): 2022 2021 Year Ended September 30, 2022 2021 Revenues $ 3,805 $ 14,832 Cost of goods sold 3,772 13,796 Gross Profit 33 1,036 Operating expenses: Consulting fees 4 115 Professional fees 24 275 General and administration 1,749 4,643 Impairment expense - 50,255 Total operating expenses 1,777 55,288 Loss from operations (1,744 ) (54,251 ) Other income (expenses) Interest expense (1 ) - Other income - 155 Total other income (expense) (1 ) 155 Net loss $ (1,745 ) $ (54,096 )

Property, Plant & Equipment (Ta

Property, Plant & Equipment (Tables)	12 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Property and equipment consist of the following (in thousands): Schedule of Property, Plant and Equipment September 30, September 30, 2022 2021 Land $ 1,151 $ 1,451 Automobiles 93 74 Signage 19 19 Furniture and equipment 2,590 3,033 Leasehold improvements 3,532 3,474 Buildings and property improvements 7,460 10,126 Computer software 59 56 Property and equipment, gross 14,904 18,233 Accumulated depreciation (5,815 ) (5,635 ) Property and equipment, net $ 9,089 $ 12,598

Inventory (Tables)

Inventory (Tables)	12 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Schedule of Inventory	Inventory consists of the following (in thousands): Schedule of Inventory September 30, September 30, 2022 2021 Raw materials $ 569 $ 866 Work-in-progress 450 543 Finished goods 1,656 1,717 Total Inventory $ 2,675 $ 3,126

Prepaid expenses and other cu_2

Prepaid expenses and other current assets (Tables)	12 Months Ended
	Sep. 30, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Prepaid Expenses and Other Current Assets	Prepaid and other current assets comprised of the following: Schedule of Prepaid Expenses and Other Current Assets September 30, September 30, 2022 2021 Prepaid expenses $ 538 $ 732 ERTC credits 201 605 Deposits and other current assets 190 850 Total prepaid expenses and other current assets $ 929 $ 2,187

Non-Controlling Interests (Tabl

Non-Controlling Interests (Tables)	12 Months Ended
	Sep. 30, 2022
Noncontrolling Interest [Abstract]
Schedule of Non-Controlling Interests in Consolidated Entities	Non-controlling interests in consolidated entities are as follows (in thousands): Schedule of Non-Controlling Interests in Consolidated Entities As of September 30, 2021 NCI Equity Share Net Loss Attributable to NCI NCI in Consolidated Entities Non-Controlling Ownership % NVD RE Corp. $ 587 $ (34 ) $ 553 36.2 % Western Coast Ventures, Inc. 1,052 (210 ) 842 49.0 % YMY Ventures, Inc. 243 56 299 50.0 % Michigan RE 1, Inc. - (54 ) (54 ) 49.0 % $ 1,882 $ (242 ) $ 1,640 As of September 30, 2022 NCI Equity Share Net Loss Attributable to NCI NCI in Consolidated Entities Non-Controlling Ownership % NVD RE Corp. $ 553 $ (37 ) $ 516 36.2 % Western Coast Ventures, Inc. 842 $ (3 ) 839 49.0 % YMY Ventures, Inc. 299 $ 30 329 50.0 % Michigan RE 1, Inc. (54 ) $ (152 ) (206 ) 49.0 % $ 1,640 $ (162 ) $ 1,478

Business Combination (Tables)

Business Combination (Tables)	12 Months Ended
	Sep. 30, 2022
Business Acquisition [Line Items]
Schedule of Purchase Consideration to Fair value of assets Acquired and Liabilities Assumed	As of September 17, 2021, the Company allocated the purchase consideration to the fair value of the assets acquired and liabilities assumed as summarized in the table below ( Schedule of Purchase Consideration to Fair value of assets Acquired and Liabilities Assumed Purchase Consideration Stock Consideration $ 2,381 Total Purchase Consideration $ 2,381 Allocation of Purchase Consideration Working Capital $ 189 Fixed Assets 14 Customer Relationships 3 License 1,762 Tradename 206 Goodwill 207 Total Purchase Consideration $ 2,381
Schedule of Unaudited Proforma Information	The following unaudited proforma condensed consolidated results of operations have been prepared as if the acquisition above occurred October 1, 2020. Schedule of Unaudited Proforma Information Year Ended September 30, 2021 Revenue $ 43,821 Net loss $ (75,427 )
Driven Deliveries Inc [Member]
Business Acquisition [Line Items]
Schedule of Liabilities Measured at Fair Value	The table below shows the warrant liability and embedded derivative liability recorded in connection with the Driven convertible notes and the subsequent fair value measurement during the year ended September 30, 2021 in USD, ( in thousands Schedule of Liabilities Measured at Fair Value Warrant Liability Derivative Liability Balance as of September 30, 2020 $ - $ - Warrants acquired 9,000 - Warrants converted into equity (4,589 ) - Change in fair value (2,415 ) - Balance as of September 30, 2021 $ 1,996 $ -
Schedule of Purchase Consideration to Fair value of assets Acquired and Liabilities Assumed	As of December 29, 2020, the Company allocated the purchase consideration to the fair value of the assets acquired and liabilities assumed as summarized in the table below ( Consideration Paid (in thousands) Schedule of Purchasre Consideration to Fair value of assets Aquired and Liabilities Assumed Consideration Paid (in thousands) Estimated fair value of common stock issued $ 40,048 Estimated fair value of warrants issued 9,000 Estimated fair value of options issued 500 Estimated fair value of debt assumed 4,389 Total consideration paid $ 53,937 Assets acquired: (in thousands) Cash and cash equivalents $ - Fixed assets 47 Other Assets 1,526 Goodwill 11,740 Intangible assets 47,900 Total assets acquired $ 61,213 Liabilities assumed: (in thousands) Accrued expenses and other current liabilities (7,276 ) Total liabilities assumed $ (7,276 ) Net assets acquired (in thousands) $ 53,937

Intangible Assets, net (Tables)

Intangible Assets, net (Tables)	12 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	Intangible assets as of September 2021, and 2020 (in thousands): Schedule of Intangible Assets Estimated Useful Life Cannabis Licenses Tradename Customer Relationship Non-compete Technology Accumulated Amortization Net Carrying Amount Balance as September 30, 2021 $ 20,092 $ 951 $ 645 $ 220 $ 418 $ (3,861 ) $ 18,465 YMY Ventures 15 - - - - - (49 ) (49 ) Western Coast Ventures, Inc. 15 - - - - - - - Yerba Buena 3 15 (1,238 ) - - - - 386 (852 ) Foothill (7LV) 15 - - - - - (523 ) (523 ) Driven Deliveries (See Note 3) 10 15 (9,315 ) (413 ) - - (413 ) 2,533 (7,608 ) JV Retail 3 3 15 (391 ) (129 ) - - - 16 (504 ) JV Retail 4 3 15 (391 ) (129 ) - - - 18 (502 ) JV Extraction 10 15 (392 ) - - - - (21 ) (413 ) Other 5 - - - - - - - Balance as September 30, 2022 $ 8,365 $ 280 $ 645 $ 220 $ 5 $ (1,501 ) $ 8,014
Schedule of Expected Amortization	The following table is a runoff of expected amortization in the following 5-year period as of September 30: Schedule of Expected Amortization 2023 $ 680 2024 680 2025 680 2026 680 2027 680 Thereafter 4,614 Intangible assets $ 8,014

Accounts payable and accrued _2

Accounts payable and accrued expenses (Tables)	12 Months Ended
	Sep. 30, 2022
Payables and Accruals [Abstract]
Schedule of Accounts Payable and Accrued Expenses	Accounts payable and accrued expenses consist of the following (in thousands): Schedule of Accounts Payable and Accrued Expenses September 30, September 30, 2022 2021 Accounts payable 1,790 $ 1,105 Accrued credit cards 14 25 Accrued interest 111 87 Accrued payroll 109 713 Accrued sales tax liability 120 148 Other 166 469 Total Accounts Payable and Accrued Expenses $ 2,310 $ 2,547

Notes Payable and Advances (Tab

Notes Payable and Advances (Tables)	12 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Schedule of Short-term Notes and Advances	The following table summarizes the Company’s short-term notes and advances, acquisition note payable, due to related party loans, and long-term debt, mortgages as of September 30, 2022, and 2021: Schedule of Short-term Notes and Advances September 30, September 30, 2022 2021 Equipment financing $ 20 $ 30 Insurance financing 230 261 Promissory note 201 359 Total notes payable and advances $ 451 $ 650 Current portion of long-term debt $ 1,000 $ - Long-term mortgages, net of current portion 1,225 2,100 Total long-term debt, net of current portion $ 2,225 $ 2,100
Schedule of Maturities of Long Term Debt	The following is a table of the 5-year runoff of our long-term debt as of September 30: Schedule of Maturities of Long Term Debt 2023 $ 1,000 2024 775 2025 450 2026 - 2027 - Thereafter - Total long-term debt 2,225 Less current portion of long-term debt: (1,000 ) Long term debt $ 1,225

Convertible debt (Tables)

Convertible debt (Tables)	12 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Schedule of Assumptions Used for Valuation of Warrants	Schedule of Assumptions Used for Valuation of Warrants Fair value of underlying common shares $ 1.78 2.10 Exercise price (converted to USD) $ 2.93 Dividend yield - Historical volatility 85 % Risk free interest rate 1.4 1.9 %
Schedule of Warrant Liability and Embedded Derivative Liability	The table below shows the warrant liability and embedded derivative liability recorded in connection with the Canaccord convertible notes and the subsequent fair value measurement for the period ended September 30, 2022, in USD, ( in thousands Schedule of Warrant Liability and Embedded Derivative Liability Warrant Liability Derivative Liability Balance as of September 30, 2021 $ - $ - Modification of debentures - 339 Change in fair value - 31 Balance as of September 30, 2022 $ - $ 370

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Schedule of Liabilities Measured at Fair Value on a Recurring Basis	The following table classifies the Company’s liabilities measured at fair value on a recurring basis into the fair value hierarchy as of September 30, 2021 (in thousands): Schedule of Liabilities Measured at Fair Value on a Recurring Basis Fair value measured at September 30, 2022 Quoted prices Significant other Significant in active observable unobservable inputs Fair value (Level 1) (Level 2) (Level 3) Warrant liability $ 55 $ - $ - $ 55 Embedded derivative liability 370 - - 370 Total fair value $ 425 $ - $ - $ 425
Schedule of Level 3 Liabilities Measured at Fair Value	Schedule of Level 3 Liabilities Measured at Fair Value Embedded Warrant Liability Derivative Liability Total Balance – September 30, 2020 $ 257 $ 592 $ 849 Warrants granted for stock-based compensation 59 - 59 Warrants issued pursuant to acquisition (see Note 9) 9,000 - 9,000 Issuance of convertible notes (66 ) (15 ) (81 ) Change in fair value (2,401 ) (577 ) (2,978 ) Cancellation of warrants pursuant to settlement agreement (4,572 ) - (4,572 ) Balance - September 30, 2021 $ 2,277 $ - $ 2,277 Warrants granted 105 - 105 Modification of debentures - 339 339 Change in fair value (2,327 ) 31 (2,296 ) Balance - September 30, 2022 $ 55 $ 370 $ 425
Summary of Weighted Average Significant Unobservable Inputs	A summary of the weighted average (in aggregate) significant unobservable inputs (Level 3 inputs) used in measuring the Company’s warrant liabilities and embedded conversion feature that are categorized within Level 3 of the fair value hierarchy as of September 30, 2022, and 2021 is as follows: Summary of Weighted Average Significant Unobservable Inputs Warrant Liability As of September 30, As of September 30, 2022 2021 Strike price $ 0.49 $ 0.48 Contractual term (years) 1.43 2.57 Volatility (annual) 100 % 74 % Risk-free rate 4.1 % 1.0 % Dividend yield (per share) 0 % 0 % Embedded Derivative Liability As of September 30, As of September 30, 2022 2021 Strike price $ 0.10 $ 0.90 Contractual term (years) 2.8 0.8 Volatility (annual) 141 % 55 % Risk-free rate 4.00 % 0.08 % Dividend yield (per share) 0.00 % 0.00 % Credit spread 14 16 % 14 16 %

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Schedule of Income Tax Expenses (Benefit)	The income tax expense (benefit) consisted of the following for the fiscal year ended September 30, 2022 and 2021: Schedule of Income Tax Expenses (Benefit) September 30, September 30, 2022 2021 Total current $ - $ - Total deferred - - Income tax expense (benefit) $ - $ -
Schedule of Reconciliation of Statutory Federal Income Tax Provision to Actual Income Tax Benefit	The following is a reconciliation of the expected statutory federal income tax provision to the actual income tax benefit for the fiscal year ended September 30, 2022 and 2021: Schedule of Reconciliation of Statutory Federal Income Tax Provision to Actual Income Tax Benefit September 30, September 30, 2022 2021 Federal statutory rate $ (4,382 ) $ (16,152 ) Permanent timing differences 3,272 12,165 Other (58 ) - Change in valuation allowance 1,168 3,987 Income tax expense $ - $ -
Schedule of Deferred Tax Assets and Liabilities	Significant components of the Company’s deferred tax assets and liabilities were as follows for the fiscal year ended September 30, 2022 and 2021: Schedule of Deferred Tax Assets and Liabilities September 30, September 30, 2022 2021 Deferred tax assets: Net operating loss carryforwards $ 10,110 $ 8,454 Equity based compensation 3,045 3,192 Impairment of investments and other property 2,011 2,362 Total deferred tax assets 15,166 14,008 Deferred tax liabilities Depreciation 39 49 Total deferred tax liabilities 39 49 Net deferred tax assets 15,127 13,959 Less valuation allowance (15,127 ) (13,959 ) Net deferred tax assets (liabilities) $ - $ -

Stock Based Compensation (Table

Stock Based Compensation (Tables)	12 Months Ended
	Sep. 30, 2022
Compensation Related Costs [Abstract]
Schedule of Fair Value of Options Granted	The fair value of options granted during the years ended September 30, 2022, and 2021 were estimated using the following weighted-average assumptions: Options: Schedule of Fair Value of Options Granted For the Years Ended September 30, 2022 2021 Exercise price $ 0.07 $ 0.28 Expected term (years) 2.52 4.39 Expected stock price volatility 124 % 74 % Risk-free rate of interest 2.42 % 0.98 % Expected dividend rate 0 % 0 %
Schedule of Stock Option Activity	A summary of option activity under the Company’s stock option plan for the year ended September 30, 2022 is presented below: Schedule of Stock Option Activity Number of Shares Weighted Average Exercise Price Total Intrinsic Value Weighted Average Remaining Contractual Life (in years) Outstanding as of October 1, 2020 5,572,916 $ 1.77 $ - 2.21 Granted 1,125,000 0.28 $ 54 4.39 Outstanding as of September 30, 2021 6,697,916 $ 1.07 $ - 2.09 Granted 1,500,000 0.07 $ - 3.00 Expired/cancelled (2,242,231 ) (0.67 ) $ - - Outstanding as of September 30, 2022 5,955,685 $ 1.07 $ - 2.90 Options vested and exercisable 5,518,185 $ 0.03 $ - 2.60
Schedule of Employee Restricted Stock Activity	A summary of employee restricted stock activity for years ended September 30, 2022 and 2021 are presented below: Schedule of Employee Restricted Stock Activity Number of Shares Weighted Average Exercise Price Outstanding as of October 1, 2020 2,471,317 1.57 Granted (1) 3,914,509 0.96 Outstanding as of September 30, 2021 6,385,826 0.93 Granted 2,637,500 0.11 Outstanding as of September 30, 2022 9,023,326 $ 0.69
Schedule of Non Employee Restricted Stock Activity	A summary of non-employee restricted stock activity under the Company’s for years ended September 30, 2022 and 2021 are presented below: Schedule of Non Employee Restricted Stock Activity Number of Shares Weighted Average Exercise Price Outstanding as of September 30, 2020 3,859,178 1.72 Granted 5,058,370 0.58 Outstanding as of September 30, 2021 8,917,548 0.99 Granted 630,000 0.67 Outstanding as of September 30, 2022 9,547,548 $ 0.97
Schedule of Warrants Outstanding	A summary of the status of the Company’s outstanding warrants as of September 30, 2022 and 2021 and changes during the year then ended are presented below: Schedule of Warrants Outstanding Number of Warrants Weighted Average Exercise Price Remaining Contractual Term Outstanding as of September 30, 2020 5,114,733 $ 2.13 1 Warrants granted – equity 32,666,266 0.53 2 Warrants expired – equity (114,300 ) 2.50 0 Warrants granted – liability 30,299,134 0.45 3.04 Warrants expired – liability (5,000,000 ) 0.20 1.51 Outstanding as of September 30, 2021 62,965,833 0.47 1.23 Warrants exercised – equity (1,000,000 ) 0.04 - Warrants granted – equity 4,173,612 0.10 2.00 Warrants expired – equity (972,117 ) 0.10 - Warrants granted – liability 615,731 0.12 2.00 Outstanding as of September 30, 2022 65,783,059 0.49 1.43
Schedule of Stock-based Compensation Expenses	Stock-based compensation expense for the years ended September 30, 2022, and 2021 was comprised of the following (in thousands): Schedule of Stock-based Compensation Expenses 2022 2021 Years Ended September 30, 2022 2021 Restricted stock awards $ 296 $ 1,935 Stock options 454 279 Warrants 263 59 Accrued stock compensation - - Total stock-based compensation $ 1,013 $ 2,273

Incorporation and Operations _2

Incorporation and Operations and Going Concern (Details Narrative) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2021	Jun. 25, 2021	Jun. 24, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Common stock, shares authorized	750,000,000	750,000,000	300,000,000	750,000,000	300,000,000
Cash equivalents, at carrying value	$ 1,500
Working capital	802
Accumulated deficit	$ 133,118	$ 115,750

Schedule of Estimated Useful Li

Schedule of Estimated Useful Life of Assets (Details)	12 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Line Items]
Property and equipment estimated useful life, description	Depreciation is calculated using the straight-line method over the estimated useful lives of the assets
Buildings [Member]
Property, Plant and Equipment [Line Items]
Property and equipment estimated useful life	20 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment estimated useful life, description	Shorter of term of lease or economic life of improvement
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and equipment estimated useful life	5 years
Signage [Member]
Property, Plant and Equipment [Line Items]
Property and equipment estimated useful life	5 years
Software and Related [Member]
Property, Plant and Equipment [Line Items]
Property and equipment estimated useful life	5 years

Schedule of Lease Costs (Detail

Schedule of Lease Costs (Details) $ in Thousands	12 Months Ended
	Sep. 30, 2022 USD ($)
Accounting Policies [Abstract]
Operating lease expense	$ 1,224
Total lease costs	$ 1,224

Schedule of Right-of-Use Assets

Schedule of Right-of-Use Assets and Lease Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 30, 2021
Accounting Policies [Abstract]
Right of use asset	$ 6,874	$ 4,235
Total assets	6,874
Operating lease liabilities – short term	580	467
Operating lease liabilities – long term	6,476	$ 3,855
Total lease liability	$ 7,056

Schedule of Lease Terms and Dis

Schedule of Lease Terms and Discount Rate (Details)	Sep. 30, 2022
Accounting Policies [Abstract]
Weighted average remaining lease term (in years) - operating lease	12 years 2 months 23 days
Weighted average discount rate - operating lease	11.04%

Schedule of Cash Flow Related t

Schedule of Cash Flow Related to Lease (Details) $ in Thousands	12 Months Ended
	Sep. 30, 2022 USD ($)
Accounting Policies [Abstract]
ROU amortization	$ 1,224
Cash paydowns of operating liability	(1,224)
ROU asset	6,874
Lease Liability	$ 7,056

Schedule of Future Minimum Leas

Schedule of Future Minimum Lease Payments (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Accounting Policies [Abstract]
2023	$ 1,337
2024	1,147
2025	1,053
2026	1,033
2027	825
Thereafter	8,345
Total future minimum lease payments	13,740
Less: Lease imputed interest	(6,684)
Total	$ 7,056

Schedule of Disaggregation of R

Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Total revenue	$ 19,291	$ 24,411
Discounts and returns	(2,728)	(3,474)
Net Revenue	16,563	20,937
Wholesale [Member]
Total revenue	4,306	5,270
Retails [Member]
Total revenue	14,867	18,432
Rentals [Member]
Total revenue		17
Other [Member]
Total revenue	$ 118	$ 692

Schedule of Computation of Dilu

Schedule of Computation of Diluted Loss (Details) - shares	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive Securities	106,037,464	73,802,591
Convertible Debt Securities [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive Securities	34,736,220	3,696,311
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive Securities	5,518,185	7,140,447
Unvested Restricted Stock Awards [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive Securities
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive Securities	65,783,059	62,965,833

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative) $ in Thousands	1 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2022 USD ($) Integer	Sep. 30, 2021 USD ($)
Property, Plant and Equipment [Line Items]
Allowance for doubtful accounts receivable		$ 79	$ 79
Adjustment of inventory		$ 88	0
Property and equipment, useful life		Depreciation is calculated using the straight-line method over the estimated useful lives of the assets
Investee losses		$ 0	234
Loss to related to investment			234
Impairment of investments		795	2,235
Impairment of goodwill		5,907
Impairment of intangible assets		$ 1,961
Income tax rate	21%	25%	25%
Operating lease expense		$ 1,224
Sublease		0	$ 17
Advertising expense		$ 266	368
Number of operating segments | Integer		1
Operating lease liability		$ 7,056
Operating lease right of use asset		$ 6,874	4,235
Minimum [Member]
Property, Plant and Equipment [Line Items]
Remaining lease terms		4 months
Maximum [Member]
Property, Plant and Equipment [Line Items]
Remaining lease terms		177 months
Accounting Standards Update 2016-02 [Member]
Property, Plant and Equipment [Line Items]
Operating lease expense		$ 1,224	599
Operating lease liability		7,100
Operating lease right of use asset		$ 6,900
Community Growth Partners Holdings, Inc [Member]
Property, Plant and Equipment [Line Items]
Loss to related to investment			233
Tilstar Medical, LLC [Member]
Property, Plant and Equipment [Line Items]
Loss to related to investment			$ 1
Unconsolidated Affiliates [Member]
Property, Plant and Equipment [Line Items]
Equity method investment, ownership percentage		5%

Schedule of Discontinued Operat

Schedule of Discontinued Operations of Assets and Liabilities (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 15, 2021
Discontinued Operations and Disposal Groups [Abstract]
Cash and cash equivalents		$ 106	$ 47
Inventory		382	509
Prepaid expenses and other current assets		887	242
Total current assets		1,375	798
Property and equipment, net		12	4
Right of use asset		328	327
Intangible assets, net		7,609	7,049
Total assets		9,324	8,178
Accounts payable and accrued expenses		5,967	7,551
Short term notes and advances		7	3
Settlement payable		92
Acquisition notes payable		409
Lease liability		218	218
Total current liabilities		6,693	7,772
Lease liability - long term		108	108
Total liabilities		6,801	$ 7,880
Revenues	3,805	14,832
Cost of goods sold	3,772	13,796
Gross Profit	33	1,036
Operating expenses:
Consulting fees	4	115
Professional fees	24	275
General and administration	1,749	4,643
Impairment expense		50,255
Total operating expenses	1,777	55,288
Loss from operations	(1,744)	(54,251)
Other income (expenses)
Interest expense	(1)
Other income		155
Total other income (expense)	(1)	155
Net loss	$ (1,745)	$ (54,096)

Discontinued Operations, Asse_3

Discontinued Operations, Assets and Liabilities Held for Sale (Details Narrative) - Discontinued Operations [Member] - Driven Deliveries Inc [Member] - USD ($) shares in Millions	Dec. 15, 2021	Sep. 30, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Stock repurchased during period, shares	11.5
Liabilities assumed	$ 7,100,000
Accounts payable	$ 210,000
Accounts payable outstanding		$ 130,000

Schedule of Property, Plant and

Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 30, 2021
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 14,904	$ 18,233
Accumulated depreciation	(5,815)	(5,635)
Property and equipment, net	9,089	12,598
Land [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,151	1,451
Automobiles [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	93	74
Signage [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	19	19
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	2,590	3,033
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	3,532	3,474
Building and Building Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	7,460	10,126
Computer Software [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 59	$ 56

Property, Plant & Equipment (De

Property, Plant & Equipment (Details Narrative) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 1,610	$ 1,930

Schedule of Inventory (Details)

Schedule of Inventory (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 30, 2021
Inventory Disclosure [Abstract]
Raw materials	$ 569	$ 866
Work-in-progress	450	543
Finished goods	1,656	1,717
Total Inventory	$ 2,675	$ 3,126

Inventory (Details Narrative)

Inventory (Details Narrative) - USD ($)	Sep. 30, 2022	Sep. 30, 2021
Inventory Disclosure [Abstract]
Inventory reserve	$ 0	$ 0

Schedule of Prepaid Expenses an

Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 30, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid expenses	$ 538	$ 732
ERTC credits	201	605
Deposits and other current assets	190	850
Total prepaid expenses and other current assets	$ 929	$ 2,187

Prepaid expenses and other cu_3

Prepaid expenses and other current assets (Details Narrative) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2021	Sep. 30, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Employee retention tax credit	$ 5,100
Employee retention tax credit receivable		$ 201

Equity method investments (Deta

Equity method investments (Details Narrative) - USD ($)			1 Months Ended	12 Months Ended
	Apr. 13, 2022	Jan. 06, 2020	Apr. 30, 2019	Sep. 30, 2022	Sep. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Sep. 30, 2019
Restructuring Cost and Reserve [Line Items]
Proceeds from sale of equity method investments				$ 1,651,000	$ 1,514,000
Tilstar Medical, LLC [Member]
Restructuring Cost and Reserve [Line Items]
Equity interest in acquiree			48%
Payments to acquire businesses, gross			$ 550,000
Decommissioning fund investments								$ 550,000
Gain on investment				$ 288,000
Community Growth Partners Holdings, Inc [Member]
Restructuring Cost and Reserve [Line Items]
Equity interest in acquiree				13%		6%	7%
Gain on investment				$ 488,000
Conversion feature		the Company issued a convertible promissory note to Community Growth Partners Holdings, Inc., (“CGS”) which acted as a line of credit. Subject to the terms and conditions of the note, CGS promised to pay the Company all of the outstanding principal together with interest on the unpaid principal balance upon the date that is twelve months after the effective date and was payable as follows: (a)The Company agreed to make several loans to CGS from time to time upon request of CGS in amounts not to exceed the principal sum of $2,000,000, (b) Payment of principal and interest shall be immediately available funds, (c) This note may be prepaid in whole or in part at any time without premium or penalty. Any partial prepayment shall be applied against the principal amount outstanding, (d) The unpaid principal amount outstanding under this note shall bear interest commencing upon the first advance at the rate of 10% per annum through the maturity date, calculated on the basis of a 365-day, until the entire indebtedness is fully paid, Upon the closing of a $2,000,000 financing by the Company, all of the principal and interest shall automatically convert into equity shares of CGS at the price obtained by the qualified financing. As of September 30, 2020, a portion of the note was converted into 7% equity. In March 2021, the balance of a note receivable was converted into an additional 6% equity leaving an equity investment of 13%.
Loans and leases		$ 2,000,000
Proceeds from sale of equity method investments	$ 1,650,000			$ 1,650,000

Note Receivable (Details Narrat

Note Receivable (Details Narrative) - USD ($)					1 Months Ended		8 Months Ended	12 Months Ended
	Apr. 13, 2022	Apr. 05, 2021	Oct. 02, 2020	Jan. 06, 2020	Mar. 31, 2021	Sep. 30, 2020	Aug. 31, 2020	Sep. 30, 2022	Sep. 30, 2021	Jan. 04, 2020
Restructuring Cost and Reserve [Line Items]
Proceeds from sale of equity method investment								$ 1,651,000	$ 1,514,000
Bushman Holding Inc [Member]
Restructuring Cost and Reserve [Line Items]
Notes payable			$ 100,000						210,000
Bad debt expense									310,000
Promissory Note [Member] | Former Employee [Member]
Restructuring Cost and Reserve [Line Items]
convertible promissory note			$ 14,000
Debt Instrument, Frequency of Periodic Payment			eighteen-month
Debt Instrument, Maturity Date			Mar. 01, 2022
Notes Receivable, Related Parties								0	$ 3,000
Convertible Promissory Note [Member]
Restructuring Cost and Reserve [Line Items]
convertible promissory note		$ 250,000
Bad debt expense		$ 257,010
Debt instrument maturity date description		The Note has a maturity date which is six months after the close of the Arkannabis, a Colorado grow facility
Debt instrument interest rate stated percentage		5.75%
Debt instrument description		The terms of the note call for automatic conversion upon the closing of the Arkannabis business of the outstanding principal and interest on this Note and will convert into that number of shares of the equity securities equivalent to a non-dilutive 12.5% of the issued and outstanding shares of the Arkannabis business
Community Growth Partners Holdings, Inc [Member]
Restructuring Cost and Reserve [Line Items]
convertible promissory note										$ 355,000
Proceeds from sale of note receivable	$ 150,000,000
Proceeds from sale of equity method investment	$ 1,650,000							$ 1,650,000
Proceeds from repayment of notes receivable				$ 2,500,000
Debt conversion, converted amount					$ 30,000
Equity interest in acquiree					6%	7%		13%
Community Growth Partners Holdings, Inc [Member] | Convertible Non-negotiable Revolving Credit Promissory Note [Member]
Restructuring Cost and Reserve [Line Items]
Line of credit, maximum borrowing capacity				$ 2,500,000
Line of credit, payment terms				four-year
Advanced payment							$ 899,700
Debt conversion, converted amount						$ 480,182

Consolidated Asset Acquisitio_2

Consolidated Asset Acquisitions (Details Narrative) - USD ($)				12 Months Ended
	Jan. 05, 2021	Jan. 04, 2021	Mar. 29, 2019	Sep. 30, 2022	Sep. 30, 2021	Apr. 13, 2021	Mar. 29, 2021
Business Acquisition [Line Items]
Issuance of shares of common stock					101,968,944
Issuance of common stock, value					$ 37,287,000
Investments					1,715,000
Impairment expense				$ 5,907,000
Impairment of investment				795,000
ILCA Holdings Inc [Member]
Business Acquisition [Line Items]
Investments			$ 2,400,000
Michigan RE1 Inc [Member] | Voting Stocks [Member]
Business Acquisition [Line Items]
Ownership percentage		51%
Definitive Agreement [Member] | W C V [Member]
Business Acquisition [Line Items]
Ownership percentage			51%
Definitive Agreement [Member] | Western Coast Ventures (WCV) [Member]
Business Acquisition [Line Items]
Capital amount			$ 2,000,000				$ 2,000,000
Issuance of shares of common stock			2,500,000
Issuance of common stock, value			$ 4,400,000
Issuance of common stock, per share			$ 1.47
Cash acquired from acquisition			$ 2,000,000
Impairment expense			$ 2,200,000
Securities Purchase Agreement [Member] | Third Party [Member]
Business Acquisition [Line Items]
Sale of stock, amount				200,000
Loss on sale of subsidiary				30,000
Securities Purchase Agreement [Member] | Michigan RE1 [Member]
Business Acquisition [Line Items]
Issuance of shares of common stock		510
Payments to Acquire Businesses, Gross	$ 400,000
Impairment of investment				$ 507,000
Subscription Agreement [Member] | Kaya Holdings Corp [Member] | Common Class B [Member]
Business Acquisition [Line Items]
Shares purchased						2,875,000
Shares purchased, value						$ 230,000
Subscription Agreement [Member] | Kaya Holdings Corp [Member] | Common Class B [Member] | Founder [Member]
Business Acquisition [Line Items]
Shares purchased						500,000
Subscription Agreement [Member] | Kaya Holdings Corp [Member] | Class B [Member]
Business Acquisition [Line Items]
Shares purchased						3,375,000

Schedule of Non-Controlling Int

Schedule of Non-Controlling Interests in Consolidated Entities (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
NCI Equity Share	$ 1,640	$ 1,882
Net Loss Attributable to NCI	(162)	(242)
NCI in Consolidated Entities	1,478	1,640
NVD RE Corp [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
NCI Equity Share	553	587
Net Loss Attributable to NCI	(37)	(34)
NCI in Consolidated Entities	$ 516	$ 553
Non-Controlling Ownership, percentage	36.20%	36.20%
Western Coast Ventures (WCV) [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
NCI Equity Share	$ 842	$ 1,052
Net Loss Attributable to NCI	(3)	(210)
NCI in Consolidated Entities	$ 839	$ 842
Non-Controlling Ownership, percentage	49%	49%
YMY Ventures, Inc [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
NCI Equity Share	$ 299	$ 243
Net Loss Attributable to NCI	30	56
NCI in Consolidated Entities	$ 329	$ 299
Non-Controlling Ownership, percentage	50%	50%
Michigan RE1 Inc [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
NCI Equity Share	$ (54)
Net Loss Attributable to NCI	(152)	(54)
NCI in Consolidated Entities	$ (206)	$ (54)
Non-Controlling Ownership, percentage	49%	49%

Schedule of Liabilities Measure

Schedule of Liabilities Measured at Fair Value (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Business Acquisition [Line Items]
Balance of derivative liability	$ 2,277	$ 849
Change in fair value	(2,327)	(2,401)
Balance of derivative liability	425	2,277
Warrant Liability [Member]
Business Acquisition [Line Items]
Balance of derivative liability	2,277	257
Balance of derivative liability	55	2,277
Driven Deliveries Inc [Member] | Warrant Liability [Member]
Business Acquisition [Line Items]
Balance of derivative liability	1,996
Warrants acquired		9,000
Warrants converted into equity		(4,589)
Change in fair value		(2,415)
Balance of derivative liability		1,996
Driven Deliveries Inc [Member] | Derivative Liability [Member]
Business Acquisition [Line Items]
Balance of derivative liability
Warrants acquired
Warrants converted into equity
Change in fair value
Balance of derivative liability

Schedule of Purchasre Considera

Schedule of Purchasre Consideration to Fair value of assets Aquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Dec. 29, 2020	Sep. 30, 2022	Sep. 30, 2021
Business Acquisition [Line Items]
Goodwill		$ 1,522	$ 7,429
Driven Deliveries Inc [Member]
Business Acquisition [Line Items]
Estimated fair value of common stock issued	$ 40,048
Estimated fair value of warrants issued	9,000
Estimated fair value of options issued	500
Estimated fair value of debt assumed	4,389
Total consideration paid	53,937
Cash and cash equivalents
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	47
Fixed assets	1,526
Goodwill	11,740
Intangible assets	47,900
Total assets acquired	61,213
Accrued expenses and other current liabilities	(7,276)
Total liabilities assumed	(7,276)
Net assets acquired	$ 53,937

Schedule of Purchase Considerat

Schedule of Purchase Consideration to Fair value of assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Sep. 17, 2021	Sep. 30, 2022	Sep. 30, 2021
Business Acquisition [Line Items]
Goodwill		$ 1,522	$ 7,429
Marijuana Business [Member]
Business Acquisition [Line Items]
Stock Consideration	$ 2,381
Total Purchase Consideration	2,381
Working Capital	189
Fixed Assets	14
Customer Relationships	3
License	1,762
Tradename	206
Goodwill	$ 207

Schedule of Unaudited Proforma

Schedule of Unaudited Proforma Information (Details) $ in Thousands	12 Months Ended
	Sep. 30, 2021 USD ($)
Business Combination and Asset Acquisition [Abstract]
Revenue	$ 43,821
Net loss	$ (75,427)

Business Combination (Details N

Business Combination (Details Narrative) - USD ($)				12 Months Ended
	Sep. 17, 2021	Dec. 29, 2020	Dec. 29, 2020	Sep. 30, 2021	Sep. 30, 2022	Dec. 17, 2021	Sep. 30, 2020
Business Acquisition [Line Items]
Business acquisition shares				6,697,916,000	5,955,685		5,572,916
Goodwill acquired	$ 207,000		$ 11,740,000
Investments				$ 1,715,000
Driven Deliveries Inc [Member]
Business Acquisition [Line Items]
Business acquisition ownership percentage		100%	100%
Shares issued to acquire assets, shares		101,968,944
Business acquisition shares		4,530,495	4,530,495
purchase of warrants		30,249,184	30,249,184
Exercise price, per share		$ 0.45	$ 0.45
Impairment expense				$ 52,500,000
Accelerated Share Repurchases, Settlement (Payment) or Receipt						$ 11,500,000
Common Stock Held by Subsidiary						7,900,000
Accounts payable						$ 210,753
Marijuana Business [Member]
Business Acquisition [Line Items]
Shares issued to acquire assets, shares	8,209,178
Shares issued to acquire assets, value	$ 2,380,661
Shares issued price per share	$ 0.29

Schedule of Intangible Assets (

Schedule of Intangible Assets (Details) $ in Thousands	12 Months Ended
	Sep. 30, 2022 USD ($)
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization Balance, beginning	$ (3,861)
Finite-Lived Intangible Assets Net Balance, beginning	18,465
Finite-Lived Intangible Assets, Accumulated Amortization Balance, beginning	(1,501)
Finite-Lived Intangible Assets Net Balance, beginning	$ 8,014
Minimum [Member] | Driven Deliveries Inc [Member]
Indefinite-Lived Intangible Assets [Line Items]
Estimated Useful Life	10 years
Maximum [Member] | Driven Deliveries Inc [Member]
Indefinite-Lived Intangible Assets [Line Items]
Estimated Useful Life	15 years
YMY Ventures LLC [Member]
Indefinite-Lived Intangible Assets [Line Items]
Estimated Useful Life	15 years
Finite-Lived Intangible Assets Gross Balance, beginning	$ (49)
Western Coast Ventures (WCV) [Member]
Indefinite-Lived Intangible Assets [Line Items]
Estimated Useful Life	15 years
Finite-Lived Intangible Assets Gross Balance, beginning
Yerba Buena, LLC [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	$ (852)
Yerba Buena, LLC [Member] | Minimum [Member]
Indefinite-Lived Intangible Assets [Line Items]
Estimated Useful Life	3 years
Yerba Buena, LLC [Member] | Maximum [Member]
Indefinite-Lived Intangible Assets [Line Items]
Estimated Useful Life	15 years
Foot Hills [Member]
Indefinite-Lived Intangible Assets [Line Items]
Estimated Useful Life	15 years
Finite-Lived Intangible Assets Gross Balance, beginning	$ (523)
Driven Deliveries Inc [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	(7,608)
JV Retail 3 [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	$ (504)
JV Retail 3 [Member] | Minimum [Member]
Indefinite-Lived Intangible Assets [Line Items]
Estimated Useful Life	3 years
JV Retail 3 [Member] | Maximum [Member]
Indefinite-Lived Intangible Assets [Line Items]
Estimated Useful Life	15 years
JV Retail 4 [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	$ (502)
JV Retail 4 [Member] | Minimum [Member]
Indefinite-Lived Intangible Assets [Line Items]
Estimated Useful Life	3 years
JV Retail 4 [Member] | Maximum [Member]
Indefinite-Lived Intangible Assets [Line Items]
Estimated Useful Life	15 years
JV Extraction [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	$ (413)
JV Extraction [Member] | Minimum [Member]
Indefinite-Lived Intangible Assets [Line Items]
Estimated Useful Life	10 years
JV Extraction [Member] | Maximum [Member]
Indefinite-Lived Intangible Assets [Line Items]
Estimated Useful Life	15 years
Other [Member]
Indefinite-Lived Intangible Assets [Line Items]
Estimated Useful Life	5 years
Cannabis Licenses [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	$ 20,092
Finite-Lived Intangible Assets Gross Balance, beginning	8,365
Cannabis Licenses [Member] | YMY Ventures LLC [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Cannabis Licenses [Member] | Western Coast Ventures (WCV) [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Cannabis Licenses [Member] | Yerba Buena, LLC [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	(1,238)
Cannabis Licenses [Member] | Foot Hills [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Cannabis Licenses [Member] | Driven Deliveries Inc [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	(9,315)
Cannabis Licenses [Member] | JV Retail 3 [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	(391)
Cannabis Licenses [Member] | JV Retail 4 [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	(391)
Cannabis Licenses [Member] | JV Extraction [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	(392)
Cannabis Licenses [Member] | Other [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Trade Name [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	951
Finite-Lived Intangible Assets Gross Balance, beginning	280
Trade Name [Member] | YMY Ventures LLC [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Trade Name [Member] | Western Coast Ventures (WCV) [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Trade Name [Member] | Yerba Buena, LLC [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Trade Name [Member] | Foot Hills [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Trade Name [Member] | Driven Deliveries Inc [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	(413)
Trade Name [Member] | JV Retail 3 [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	(129)
Trade Name [Member] | JV Retail 4 [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	(129)
Trade Name [Member] | JV Extraction [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Trade Name [Member] | Other [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Customer Relationship [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	645
Finite-Lived Intangible Assets Gross Balance, beginning	645
Customer Relationship [Member] | YMY Ventures LLC [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Customer Relationship [Member] | Western Coast Ventures (WCV) [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Customer Relationship [Member] | Yerba Buena, LLC [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Customer Relationship [Member] | Foot Hills [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Customer Relationship [Member] | Driven Deliveries Inc [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Customer Relationship [Member] | JV Retail 3 [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Customer Relationship [Member] | JV Retail 4 [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Customer Relationship [Member] | JV Extraction [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Non-Compete [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	220
Finite-Lived Intangible Assets Gross Balance, beginning	220
Non-Compete [Member] | YMY Ventures LLC [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Non-Compete [Member] | Western Coast Ventures (WCV) [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Non-Compete [Member] | Yerba Buena, LLC [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Non-Compete [Member] | Foot Hills [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Non-Compete [Member] | Driven Deliveries Inc [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Non-Compete [Member] | JV Retail 3 [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Non-Compete [Member] | JV Retail 4 [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Non-Compete [Member] | JV Extraction [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Technology [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	418
Finite-Lived Intangible Assets Gross Balance, beginning	5
Technology [Member] | YMY Ventures LLC [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Technology [Member] | Western Coast Ventures (WCV) [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Technology [Member] | Yerba Buena, LLC [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Technology [Member] | Foot Hills [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Technology [Member] | Driven Deliveries Inc [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	(413)
Technology [Member] | JV Retail 3 [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Technology [Member] | JV Retail 4 [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Technology [Member] | JV Extraction [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Accumulated Amortization [Member] | YMY Ventures LLC [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	(49)
Accumulated Amortization [Member] | Western Coast Ventures (WCV) [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning
Accumulated Amortization [Member] | Yerba Buena, LLC [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	386
Accumulated Amortization [Member] | Foot Hills [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	(523)
Accumulated Amortization [Member] | Driven Deliveries Inc [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	2,533
Accumulated Amortization [Member] | JV Retail 3 [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	16
Accumulated Amortization [Member] | JV Retail 4 [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	18
Accumulated Amortization [Member] | JV Extraction [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets Gross Balance, beginning	$ (21)

Schedule of Expected Amortizati

Schedule of Expected Amortization (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
2023	$ 680
2024	680
2025	680
2026	680
2027	680
Thereafter	4,614
Intangible assets	$ 8,014	$ 18,465

Intangible Assets, net (Details

Intangible Assets, net (Details Narrative) - USD ($)	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 881,000	$ 3,460

Schedule of Accounts Payable an

Schedule of Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 30, 2021
Payables and Accruals [Abstract]
Accounts payable	$ 1,790	$ 1,105
Accrued credit cards	14	25
Accrued interest	111	87
Accrued payroll	109	713
Accrued sales tax liability	120	148
Other	166	469
Total Accounts Payable and Accrued Expenses	$ 2,310	$ 2,547

Schedule of Short-term Notes an

Schedule of Short-term Notes and Advances (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 30, 2021
Debt Disclosure [Abstract]
Equipment financing	$ 20	$ 30
Insurance financing	230	261
Promissory note	201	359
Total notes payable and advances	451	650
Current portion of long-term debt	1,000
Long-term mortgages, net of current portion	1,225	2,100
Total long-term debt, net of current portion	$ 2,225	$ 2,100

Schedule of Maturities of Long

Schedule of Maturities of Long Term Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 30, 2021
Debt Disclosure [Abstract]
2023	$ 1,000
2024	775
2025	450
2026
2027
Thereafter
Total long-term debt, net of current portion	2,225	$ 2,100
Less current portion of long-term debt:	(1,000)
Long term debt	$ 1,225	$ 2,100

Notes Payable and Advances (Det

Notes Payable and Advances (Details Narrative) - USD ($)

1 Months Ended

12 Months Ended

Jul. 31, 2022

Jul. 07, 2022

May 23, 2022

Apr. 06, 2022

Apr. 05, 2022

Feb. 24, 2022

Feb. 14, 2022

Aug. 30, 2021

Jul. 17, 2021

Jul. 16, 2021

May 31, 2021

Apr. 17, 2021

Apr. 10, 2021

Feb. 24, 2021

Feb. 17, 2021

Dec. 04, 2020

Nov. 23, 2020

Jul. 31, 2020

Jul. 31, 2020

Jul. 02, 2020

Apr. 29, 2018

Jul. 31, 2017

Sep. 30, 2022

Oct. 31, 2021

Jan. 31, 2021

Nov. 30, 2020

Aug. 31, 2020

Jul. 31, 2020

Mar. 31, 2020

Jan. 31, 2020

Apr. 30, 2018

Sep. 30, 2022

Sep. 30, 2020

Apr. 30, 2022

Feb. 09, 2022

Oct. 26, 2021

Sep. 30, 2021

Dec. 29, 2020

Jul. 15, 2020

Jun. 25, 2020

Jun. 03, 2020

May 31, 2020

May 01, 2020

Jan. 30, 2020

Sep. 30, 2019

Mulino Property [Member]

Short-Term Debt [Line Items]

Debt instrument periodic payment

$ 13,750

Mortgage loan interest rate

15%

Finance Lease, Liability

$ 1,094,989

Base rental fee

$ 29,167

Base rental fee percentage

2%

Proceeds from transaction amount

$ 1,800,000

NVD RE Corp [Member]

Short-Term Debt [Line Items]

Debt instrument periodic payment

$ 4,667

Long term debt

$ 300,000

Debt instrument interest rate stated percentge

37.50%

Due to related party

$ 1,275,000

Payments to acquire business gross

600,000

Payments for tenant

$ 675,000

January 2020 [Member]

Short-Term Debt [Line Items]

Mortgage loan interest rate

12%

Mortgage face amount

$ 450,000

$ 450,000

Payment term

three-year term

March 2020 [Member]

Short-Term Debt [Line Items]

Mortgage loan interest rate

12%

Mortgage face amount

775,000

$ 775,000

Payment term

two-year term.

Driven Deliveries Inc [Member]

Short-Term Debt [Line Items]

Common stock purchase warrants issued

30,249,184

Warrants and rights, per share

$ 0.45

Settlement payable

250,451

$ 250,451

Related Party Transaction, Terms and Manner of Settlement

This settlement is payable in equal bi-monthly payments over a period of seventeen (17) Months (36 pay periods), beginning in February 2021

Long-Term Debt

$ 92,045

Private Placement [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 500,000

Long term debt

$ 250,000

Debt instrument interest rate stated percentge

10%

Warrants and rights, per share

$ 0.07

Common shares warrant purchase

500,000

Extension fee

$ 5,000

Repayment of debt

$ 250,000

Paycheck Protection Program [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 220,564

$ 220,564

$ 220,564

$ 140,407

$ 62,500

$ 245,400

$ 266,820

Debt Instrument, Maturity Date

Jun. 03, 2022

2017 Tractor [Member]

Short-Term Debt [Line Items]

Long term debt

0

$ 0

Notes Payable One [Member]

Short-Term Debt [Line Items]

Long term debt

0

0

0

Promissory Note [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 27,880

Debt instrument periodic payment

$ 642

Long term debt

20,465

20,465

Debt instrument interest rate stated percentge

13.29%

Notes Payable Nine [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 58,899

Debt instrument periodic payment

$ 4,113

Debt instrument interest rate stated percentge

7.99%

Debt instrument down payment

$ 17,769

Two Promissory Note [Member]

Short-Term Debt [Line Items]

Warrants and rights, per share

$ 0.45

$ 0.45

$ 0.45

$ 0.45

Warrant description

As of July 2020, in consideration of the warrants being amended to $0.45 per share with an extended the term from five to a ten-year term, the maturity date has been extended to December 13, 2020. In May 2020, the Company made a principal payment of $20,000

Debt instrument principal payment

$ 20,000

Two Promissory Note [Member] | Minimum [Member]

Short-Term Debt [Line Items]

Warrants and rights outstanding term

5 years

5 years

5 years

Two Promissory Note [Member] | Maximum [Member]

Short-Term Debt [Line Items]

Warrants and rights outstanding term

10 years

10 years

10 years

Two Promissory Note [Member] | Accredited Investors [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 500,000

Debt instrument interest rate stated percentge

12%

Warrants and rights outstanding term

5 years

Warrants and rights, per share

$ 0.85

Two Promissory Note [Member]

Short-Term Debt [Line Items]

Warrants and rights outstanding term

10 years

10 years

10 years

5 years

5 years

Warrant description

As of July 2020, in consideration of the warrants being amended to $0.45 per share with an extended the term from five to a ten-year term, the maturity date has been extended to December 13, 2020

Debt discount

49,452

49,452

66,004

Two Promissory Note [Member] | Minimum [Member]

Short-Term Debt [Line Items]

Long term debt

250,000

250,000

425,000

Two Promissory Note [Member] | Maximum [Member]

Short-Term Debt [Line Items]

Long term debt

200,548

200,548

358,996

Two Promissory Note [Member] | Accredited Investors [Member]

Short-Term Debt [Line Items]

Common stock purchase warrants issued

100,000

Subsidaries Owned [Member]

Short-Term Debt [Line Items]

Long term debt

220,565

Paycheck Protection Program [Member]

Short-Term Debt [Line Items]

Long term debt

266,820

Paycheck Protection Program Loan [Member]

Short-Term Debt [Line Items]

Long term debt

245,400

Paycheck Protection Program Loan One [Member]

Short-Term Debt [Line Items]

Long term debt

62,500

Paycheck Protection Program Loan Two [Member]

Short-Term Debt [Line Items]

Long term debt

$ 140,407

Long-Term Debt, Mortgages [Member]

Short-Term Debt [Line Items]

Mortgage loan interest rate

15%

Mortgage loan maturity date

Jan. 31, 2022

Debt Instrument, Collateral

The note has been cross guaranteed by the former CEO and Director of the Company

Payments of debt restructuring cost

400,000

Long-Term Debt, Mortgages Two [Member]

Short-Term Debt [Line Items]

Mortgage loan interest rate

11.55%

Mortgage loan maturity date

Apr. 01, 2022

Mortgage face amount

400,000

$ 400,000

400,000

Mortgage paid

$ 38,000

Long-Term Debt, Mortgages Three [Member]

Short-Term Debt [Line Items]

Repayment of debt

700,000

Mortgage loan interest rate

14%

15%

Mortgage loan maturity date

Jul. 31, 2023

Long-Term Debt, Mortgages Four [Member]

Short-Term Debt [Line Items]

Long term debt

200,000

200,000

Long-term Debt Mortgages Five [Member]

Short-Term Debt [Line Items]

Long term debt

400,000

400,000

Mortgage loan interest rate

14%

Payment of debt

$ 300,000

36-Month Premium Finance Agreement [Member] | Notes Payable [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 15,710

Debt instrument periodic payment

$ 442

60-Month Premium Finance Agreement [Member] | Notes Payable [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 28,905

Debt instrument periodic payment

$ 482

12-Month Premium Finance Agreement [Member] | Notes Payable One [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 243,284

Debt instrument periodic payment

$ 17,835

Debt instrument interest rate stated percentge

7.46%

Debt instrument down payment

$ 47,100

12-Month Premium Finance Agreement [Member] | Notes Payable 3 [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 13,694

Debt instrument periodic payment

$ 1,199

Debt instrument interest rate stated percentge

7.369%

Debt instrument down payment

$ 3,424

12-Month Premium Finance Agreement [Member] | Notes Payable Four [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 78,750

Debt instrument periodic payment

$ 7,271

Debt instrument interest rate stated percentge

8.35%

Debt instrument down payment

$ 15,750

12-Month Premium Finance Agreement [Member] | Notes Payable Five [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 23,014

Debt instrument periodic payment

$ 1,814

Debt instrument interest rate stated percentge

11.98%

Debt instrument down payment

$ 4,871

12-Month Premium Finance Agreement [Member] | Notes Payable 6 [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 8,906

Debt instrument periodic payment

$ 741

Debt instrument interest rate stated percentge

10.25%

Debt instrument down payment

$ 2,537

12-Month Premium Finance Agreement [Member] | Notes Payable 7 [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 11,830

Debt instrument periodic payment

$ 771

Debt instrument interest rate stated percentge

1.06%

Debt instrument down payment

$ 4,113

12-Month Premium Finance Agreement [Member] | Notes Payable Eight [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 16,850

Debt instrument periodic payment

$ 1,351

Debt instrument interest rate stated percentge

3.96%

12-Month Premium Finance Agreement [Member] | Notes Payable Nine [Member]

Short-Term Debt [Line Items]

Proceeds from loans

94,116

Debt instrument periodic payment

$ 7,446

12,188

Debt instrument interest rate stated percentge

11.26%

Debt instrument down payment

$ 27,102

12-Month Premium Finance Agreement [Member] | Notes Payable Ten [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 10,411

Debt instrument periodic payment

$ 866

Debt instrument interest rate stated percentge

10.65%

Debt instrument down payment

$ 1,751

12-Month Premium Finance Agreement [Member] | Notes Payable Eleven [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 430,657

Debt instrument periodic payment

$ 35,795

Long term debt

107,386

107,386

Debt instrument interest rate stated percentge

7.64%

Debt instrument down payment

$ 86,131

12-Month Premium Finance Agreement [Member] | Notes Payable Twelve [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 17,551

Debt instrument periodic payment

$ 1,327

Long term debt

3,981

3,981

Debt instrument interest rate stated percentge

7.37%

Debt instrument down payment

$ 18,033

12-Month Premium Finance Agreement [Member] | Notes Payable Thirteen [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 29,060

Debt instrument periodic payment

$ 2,697.47

Long term debt

10,790

10,790

Debt instrument interest rate stated percentge

9.65%

Debt instrument down payment

$ 5,812

12-Month Premium Finance Agreement [Member] | Notes Payable Fourteen [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 7,599

Debt instrument periodic payment

$ 640.41

Long term debt

3,842

3,842

Debt instrument interest rate stated percentge

11.50%

Debt instrument down payment

$ 2,121

12-Month Premium Finance Agreement [Member] | Notes Payable Fifteen [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 20,931

Debt instrument periodic payment

$ 1,808.22

Long term debt

7,233

7,233

Debt instrument interest rate stated percentge

10.50%

Debt instrument down payment

$ 5,347

12-Month Premium Finance Agreement [Member] | Notes Payable Sixteen [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 10,150

Debt instrument periodic payment

$ 837

Debt instrument interest rate stated percentge

11%

Debt instrument down payment

$ 3,950

12-Month Premium Finance Agreement [Member] | Notes Payable Seventeen [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 144,500

Debt instrument periodic payment

$ 11,348

Debt instrument interest rate stated percentge

9.49%

Debt instrument down payment

$ 35,803

10-month Premium Finance Agreement [Member] | Notes Payable 2 [Member]

Short-Term Debt [Line Items]

Proceeds from loans

$ 9,920

Debt instrument periodic payment

$ 754

Debt instrument interest rate stated percentge

12.80%

Debt instrument down payment

$ 2,383

12-Month Premium Finance Agreement [Member] | Notes Payable Sixteen [Member]

Short-Term Debt [Line Items]

Long term debt

5,861

5,861

12-Month Premium Finance Agreement [Member] | Notes Payable Seventeen [Member]

Short-Term Debt [Line Items]

Long term debt

$ 90,784

$ 90,784

Schedule of Assumptions Used fo

Schedule of Assumptions Used for Valuation of Warrants (Details) - Warrants Granted [Member] - Convertible Debt [Member]	Sep. 30, 2022 $ / shares
Measurement Input, Exercise Price [Member]
Short-Term Debt [Line Items]
Exercise price	$ 2.93
Measurement Input, Expected Dividend Rate [Member]
Short-Term Debt [Line Items]
Warrant right outstanding measurement input
Measurement Input, Option Volatility [Member]
Short-Term Debt [Line Items]
Warrant right outstanding measurement input	85
Minimum [Member]
Short-Term Debt [Line Items]
Share price	$ 1.78
Minimum [Member] | Measurement Input, Risk Free Interest Rate [Member]
Short-Term Debt [Line Items]
Warrant right outstanding measurement input	1.4
Maximum [Member]
Short-Term Debt [Line Items]
Share price	$ 2.10
Maximum [Member] | Measurement Input, Risk Free Interest Rate [Member]
Short-Term Debt [Line Items]
Warrant right outstanding measurement input	1.9

Schedule of Warrant Liability a

Schedule of Warrant Liability and Embedded Derivative Liability (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Modification of debentures	$ 339
Change in fair value	(31)	$ 577
Warrant Liability [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Beinning Balance
Modification of debentures
Change in fair value
Ending Balance
Derivative Liability [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Beinning Balance
Modification of debentures	339
Change in fair value	31
Ending Balance	$ 370

Convertible debt (Details Narra

Convertible debt (Details Narrative)				1 Months Ended					12 Months Ended
	Mar. 14, 2019 USD ($) shares	Mar. 14, 2019 CAD ($) $ / shares shares	Dec. 27, 2018 CAD ($) shares	Jun. 30, 2022 $ / shares	Jan. 31, 2019 USD ($) shares	Jan. 31, 2019 CAD ($) $ / shares shares	Dec. 31, 2018 USD ($) shares	Dec. 31, 2018 CAD ($) $ / shares shares	Sep. 30, 2022 USD ($) shares	Sep. 30, 2022 CAD ($) shares	Sep. 30, 2021 USD ($) shares	Sep. 30, 2022 CAD ($) $ / shares	Apr. 30, 2020 $ / shares
Short-Term Debt [Line Items]
Convertible debentures converted											$ 4,913,000
Shares issued, value									$ 285,000		2,870,000
Fair value of warrants									(2,327,000)		$ (2,401,000)
Common Stock [Member]
Short-Term Debt [Line Items]
Common stock shares convenvertible securities | shares											9,480,259
Convertible debentures converted											$ 10,000
Shares issued, value									3,000		$ 7,000
Warrant Holders [Member]
Short-Term Debt [Line Items]
Exercise price, per share | $ / shares				$ 1,000
Debt instrument conversion price | $ / shares				$ 0.80									$ 1.90
Share price | $ / shares													1.87
Debt instrument prepayment percentage				5%
Warrant Holders [Member] | Convertible Debt One [Member]
Short-Term Debt [Line Items]
Debt discount									0
Extinguishment of debt									803,000
Convertible debt									2,900,000
Warrant Holders [Member] | Convertible Debt [Member]
Short-Term Debt [Line Items]
Debt discount									1,100,000
Convertible debt									1,500,000
Convertible Debentures [Member] | Warrant Holders [Member]
Short-Term Debt [Line Items]
Exercise price, per share | $ / shares				$ 0.20									1.50
Share price | $ / shares				$ 0.10									$ 1.15
Convertible Debt [Member]
Short-Term Debt [Line Items]
Debt discount									$ 1,200,000
Canaccord Genuity Inc., [Member]
Short-Term Debt [Line Items]
Convertible debentures converted										$ 1,000
Debt instrument interest rate stated percentage									105%			105%
Debt instrument conversion price | $ / shares												$ 3
Debt conversion, shares issued | shares									333.33	333.33
Fair value of warrants									$ 424,000
Canaccord Genuity Inc., [Member] | Common Stock [Member]
Short-Term Debt [Line Items]
Finance fee												$ 50,000
Shares issued, value									$ 50,000
Canaccord Genuity Inc., [Member] | Agents [Member]
Short-Term Debt [Line Items]
Cash commission percentage									7%	7%
Canaccord Genuity Inc., [Member] | Indenture Trustee [Member]
Short-Term Debt [Line Items]
Debt instrument interest rate stated percentage									25%			25%
Canaccord Genuity Inc., [Member] | 8% Convertible Notes [Member]
Short-Term Debt [Line Items]
Proceeds from private offerings									$ 3,100,000	$ 4,100,000
Canaccord Genuity Inc., [Member] | 8.0% Senior Unsecured Convertible Debenture [Member]
Short-Term Debt [Line Items]
Exercise price, per share | $ / shares												$ 3.90
Convertible debt												$ 1,000
Debt instrument interest rate stated percentage									8%			8%
Debt instrument, description									upon the exercise thereof and at no additional cost, 1.05 Convertible Debenture Units per CD Special Warrant (instead of 1.0 Convertible Debenture Unit per CD Special Warrant). Until the Receipt and Registration have been obtained, securities issued in connection with the Offering (including any underlying securities issued upon conversion or exercise thereof) will be subject to a six (6)-month hold period from the date of issue. Since the CD Special Warrants were exchanged for Convertible Debenture Units after six (6) months as U.S. and Canadian registrations were not effective at that time, the holders received 1.05 Convertible Debenture Units per CD Special Warrant.	upon the exercise thereof and at no additional cost, 1.05 Convertible Debenture Units per CD Special Warrant (instead of 1.0 Convertible Debenture Unit per CD Special Warrant). Until the Receipt and Registration have been obtained, securities issued in connection with the Offering (including any underlying securities issued upon conversion or exercise thereof) will be subject to a six (6)-month hold period from the date of issue. Since the CD Special Warrants were exchanged for Convertible Debenture Units after six (6) months as U.S. and Canadian registrations were not effective at that time, the holders received 1.05 Convertible Debenture Units per CD Special Warrant.
Payments to broker									$ 1,900,000			$ 2,500,000
CD Special Warrant [Member] | Private Offering [Member]
Short-Term Debt [Line Items]
Convertible debentures converted	$ 700,000	$ 1,000,000
CD Special Warrant [Member] | Private Offering [Member] | Canaccord Genuity Inc., [Member]
Short-Term Debt [Line Items]
Common stock shares convenvertible securities | shares			10,000
Proceeds from private offerings			$ 10,000,000
Number of warrant shares issued | shares		962				3,121		3,121
Exercise price, per share | $ / shares		$ 1,000				$ 1,000		$ 1,000
Convertible debentures converted					$ 2,300,000	$ 3,100,000	$ 2,300,000	$ 3,100,000
Broker CD Special Warrant [Member] | Canaccord Genuity Inc., [Member] | Agents [Member]
Short-Term Debt [Line Items]
Cash commission percentage									7%	7%
Broker CD Special Warrant [Member] | Private Offering [Member]
Short-Term Debt [Line Items]
Common stock shares convenvertible securities | shares	5,600	5,600
Broker CD Special Warrant [Member] | Private Offering [Member] | Canaccord Genuity Inc., [Member]
Short-Term Debt [Line Items]
Common stock shares convenvertible securities | shares					52,430	52,430	52,430	52,430
Broker Warrant [Member] | Canaccord Genuity Inc., [Member]
Short-Term Debt [Line Items]
Exercise price, per share | $ / shares												$ 1,000
Commission fee										$ 157,290
Commission and finance fee plus additional expenses										20,000
Legal Fees										$ 181,365
Offering fee and expense									$ 320,000

Schedule of Liabilities Measu_2

Schedule of Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 30, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	$ 55	$ 2,277
Embedded derivative liability	370
Total fair value	425
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability
Embedded derivative liability
Total fair value
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability
Embedded derivative liability
Total fair value
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	55
Embedded derivative liability	370
Total fair value	$ 425

Schedule of Level 3 Liabilities

Schedule of Level 3 Liabilities Measured at Fair Value (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Balance of derivative liability	$ 2,277	$ 849
Warrants granted for stock-based compensation	105	59
Issuance of convertible notes		(81)
Change in fair value	(2,296)	(2,978)
Cancellation of warrants pursuant to settlement agreement		(4,572)
Modification of debentures	339
Balance of derivative liability	425	2,277
Warrant Liability [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Balance of derivative liability	2,277	257
Warrants granted for stock-based compensation	105	59
Issuance of convertible notes		(66)
Change in fair value	(2,327)	(2,401)
Cancellation of warrants pursuant to settlement agreement		(4,572)
Modification of debentures
Balance of derivative liability	55	2,277
Embedded Derivative Liability [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Balance of derivative liability		592
Warrants granted for stock-based compensation
Issuance of convertible notes		(15)
Change in fair value	31	(577)
Cancellation of warrants pursuant to settlement agreement
Modification of debentures	339
Balance of derivative liability	$ 370

Summary of Weighted Average Sig

Summary of Weighted Average Significant Unobservable Inputs (Details)	Sep. 30, 2022 $ / shares	Sep. 30, 2021 $ / shares
Measurement Input, Price Volatility [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input	1.5
Measurement Input, Price Volatility [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input	4
Measurement Input, Credit Spread [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input	1
Measurement Input, Credit Spread [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input	1
Warrant Liability [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Exercise price, per share	$ 0.49	$ 0.48
Contractual term (years)	1 year 5 months 4 days	2 years 6 months 25 days
Warrant Liability [Member] | Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input	100	74
Warrant Liability [Member] | Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input	4.1	1
Warrant Liability [Member] | Measurement Input, Expected Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input	0	0
Embedded Derivative Liability [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Exercise price, per share	$ 0.10	$ 0.90
Contractual term (years)	2 years 9 months 18 days	9 months 18 days
Embedded Derivative Liability [Member] | Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	141	55
Embedded Derivative Liability [Member] | Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	4	0.08
Embedded Derivative Liability [Member] | Measurement Input, Expected Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0	0
Embedded Derivative Liability [Member] | Measurement Input, Credit Spread [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	14	14
Embedded Derivative Liability [Member] | Measurement Input, Credit Spread [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	16	16

Fair Value Measurements (Detail

Fair Value Measurements (Details Narrative)	12 Months Ended
	Sep. 30, 2022
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value assumption, description	The Company used a lattice based trinomial model developed by Tsiveriotis, K. and Fernades in which the three lattices incorporate (1) the Company’s underlying common stock price; (2) the value of the debt components of the convertible notes; and (3) the value of the equity component of the convertible notes. The main drivers of sensitivity for the model are volatility and the credit spread. The model used will vary by approximately 1.5% for a 4% change in volatility and will vary by less than 1% for each 1% change in credit spread.
Measurement Input, Price Volatility [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Change in measurement input	1.5
Measurement Input, Price Volatility [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Change in measurement input	4
Measurement Input, Credit Spread [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Change in measurement input	1
Measurement Input, Credit Spread [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Change in measurement input	1

Schedule of Income Tax Expenses

Schedule of Income Tax Expenses (Benefit) (Details) - USD ($)	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Total current
Total deferred
Income tax expense (benefit)

Schedule of Reconciliation of S

Schedule of Reconciliation of Statutory Federal Income Tax Provision to Actual Income Tax Benefit (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Federal statutory rate	$ (4,382)	$ (16,152)
Permanent timing differences	3,272	12,165
Other	(58)
Change in valuation allowance	1,168	3,987
Income tax expense (benefit)

Schedule of Deferred Tax Assets

Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	Sep. 30, 2022	Sep. 30, 2021
Deferred tax assets:
Net operating loss carryforwards	$ 10,110	$ 8,454
Equity based compensation	3,045	3,192
Impairment of investments and other property	2,011	2,362
Total deferred tax assets	15,166	14,008
Deferred tax liabilities
Depreciation	39	49
Total deferred tax liabilities	39	49
Net deferred tax assets	15,127	13,959
Less valuation allowance	(15,127)	(13,959)
Net deferred tax assets (liabilities)

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2022	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Income tax description		the expected tax benefit, temporary timing differences and long-term timing differences are calculated at the 25% statutory rate	the expected tax benefit, temporary timing differences and long-term timing differences are calculated at the 25% statutory rate
Statutory rate	21%	25%	25%
Operating loss carryforwards, net		$ 40
Net operating loss carryforwards expiring year		expire beginning in 2038.

Shareholders_ Equity (Details N

Shareholders’ Equity (Details Narrative) - USD ($)	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2021	Jun. 25, 2021	Jun. 24, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized	750,000,000	750,000,000	300,000,000	750,000,000	300,000,000
Common stock issued for stock compensation		3,914,509
Stock issued during the period, value	$ 285,000	$ 2,870,000
Common stock issued for stock compensation, value		$ 1,675,000
Stock Issued During Period, Shares, Other		1,465,117
Proceeds from Issuance or Sale of Equity		$ 630,000
Common stock issued in connection with conversion of notes payable		$ 4,913,000
Acquisition of Driven Deliveries, Inc., shares		101,968,944
Private Placement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during the period		5,322,136
Stock issued during the period, value		$ 4,892,000
Related to Rent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock issued for stock compensation		293,700
Common stock issued for stock compensation, value		$ 117,480
Related to Deposit [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during the period		300,000
Stock issued during the period, value		$ 210,000
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares cancelled		694,233
Common Stock [Member] | Commission Expense [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during the period		90,909
Stock issued during the period, value		$ 40,000
Common Stock [Member] | Stock Option Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during the period		10,000
Convertible Debt [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during the period	1,751,186
Stock issued during the period, value	$ 121,000
Common stock issued in connection with conversion of notes payable, shares	289,750
Accrued Interest Related to Convertible Notes [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock issued in connection with conversion of notes payable, shares		553,417
Common stock issued in connection with conversion of notes payable		$ 309,121
Convertible Notes [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock issued in connection with conversion of notes payable, shares		9,480,259
Common stock issued in connection with conversion of notes payable		$ 4,913,000
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock issued for stock compensation	3,137,500
Shares issued for compensation, value	$ 313,000
Stock issued during the period	3,223,611	6,833,069
Stock issued during the period, value	$ 3,000	$ 7,000
Common stock issued in connection with conversion of notes payable, shares		9,480,259
Stock Issued During Period, Shares, Other		1,465,117
Common stock issued in connection with conversion of notes payable		$ 10,000
Acquisition of Driven Deliveries, Inc., shares		101,968,944
[custom:StockIssuedDuringPeriodSharesPurchaseOfAsset]		8,209,178
[custom:StockIssuedDuringPeriodValuePurchaseOfAsset]		$ 2,380,661
Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock issued for stock compensation	3,223,611
Shares issued for compensation, value	$ 285,000
Consulting Agreements [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during the period	130,000	4,790,070
Stock issued during the period, value	$ 30,000	$ 2,032,000
Consulting Agreements [Member] | Convertible Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares cancelled		525,400
Consulting Agreements [Member] | Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issued price per share		$ 0.29
Consulting Agreements [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issued price per share		$ 0.51
Share Exchange Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares received from agreement	11,506,700
Subscription Agreements [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares cancelled		58,140
Settlement Agreements [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during the period		500,000
Stock issued during the period, value		$ 5,439,855
Canadian Prospectus [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during the period		19,276,340
Stock issued during the period, value		$ 7,919,000,000
Driven Deliveries Inc S-1 Registration [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during the period		2,869,889
Stock issued during the period, value		$ 6,833,069

Schedule of Fair Value of Optio

Schedule of Fair Value of Options Granted (Details) - Share-Based Payment Arrangement, Option [Member] - $ / shares	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Exercise price	$ 0.07	$ 0.28
Expected term (years)	2 years 6 months 7 days	4 years 4 months 20 days
Expected stock price volatility	124%	74%
Risk-free rate of interest	2.42%	0.98%
Expected dividend rate	0%	0%

Schedule of Stock Option Activi

Schedule of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Compensation Related Costs [Abstract]
Number of Options, Outstanding Beginning Balance	6,697,916,000	5,572,916
Weighted Average Exercise Price, Outstanding Beginning Balance	$ 1.07	$ 1.77
Aggregate Intrinsic Value, Beginning Balance
Weighted Average Remaining Contractual Term, Ending Balance	2 years 10 months 24 days	2 years 1 month 2 days	2 years 2 months 15 days
Number of Options, Granted	1,500,000	1,125,000
Weighted Average Exercise Price, Granted	$ 0.07	$ 0.28
Aggregate intrinsic value, granted		$ 54
Weighted Average Remaining Contractual Term, Granted	3 years	4 years 4 months 20 days
Number of Options, Outstanding Ending Balance	5,955,685	6,697,916,000	5,572,916
Weighted Average Exercise Price, Outstanding Ending Balance	$ 1.07	$ 1.07	$ 1.77
Aggregate Intrinsic Value, Ending Balance
Number of Options, Vested and Exercisable	5,518,185
Weighted Average Exercise Price, Vested and Exercisable	$ 0.03
Aggregate Intrinsic Value, Vested and Exercisable
Weighted Average Remaining Contractual Term, Vested and Exercisable	2 years 7 months 6 days

Schedule of Employee Restricted

Schedule of Employee Restricted Stock Activity (Details) - Restricted Stock [Member] - $ / shares	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares, beginning balance	6,385,826	2,471,317
Weighted average exercise price, beginning balance	$ 0.93	$ 1.57
Number of shares, Granted	2,637,500	3,914,509
Weighted average exercise price, granted	$ 0.11	$ 0.96
Number of shares, ending balance	9,023,326	6,385,826
Weighted average exercise price, ending balance	$ 0.69	$ 0.93

Schedule of Non Employee Restri

Schedule of Non Employee Restricted Stock Activity (Details) - Non Employee Restricted Stock [Member] - $ / shares	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares, beginning balance	8,917,548	3,859,178
Weighted average exercise price, beginning balance	$ 0.99	$ 1.72
Number of shares, Granted	630,000	5,058,370
Weighted average exercise price, granted	$ 0.67	$ 0.58
Number of shares, ending balance	9,547,548	8,917,548
Weighted average exercise price, ending balance	$ 0.97	$ 0.99

Schedule of Warrants Outstandin

Schedule of Warrants Outstanding (Details) - Warrant [Member] - $ / shares	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares, beginning balance	62,965,833	5,114,733
Weighted average exercise price, beginning balance	$ 0.47	$ 2.13
Remaining contractual term, beginning balance		1 year
Numbers of warrants, granted (Equity)	4,173,612	32,666,266
Weighted average exercise price, granted (Equity)	$ 0.10	$ 0.53
Remaining contractual term, granted (Equity)	2 years	2 years
Numbers of warrants, expired	(972,117)	(114,300)
Weighted average exercise price, expired	$ 0.10	$ 2.50
Remaining contractual term, granted (Equity)		0 years
Numbers of warrants, granted (Liability)	615,731	30,299,134
Weighted average exercise price, granted (Liability)	$ 0.12	$ 0.45
Remaining contractual term, granted (Liability)	2 years	3 years 14 days
Numbers of warrants, expired (Liability)		(5,000,000)
Weighted average exercise price, expired (Liability)		$ 0.20
Remaining contractual term, expired (Liability)		1 year 6 months 3 days
Remaining contractual term, beginning balance	1 year 2 months 23 days
Numbers of warrants, exercised	(1,000,000)
Weighted average exercise price, expired (Liability)	$ 0.04
Number of shares, ending balance	65,783,059	62,965,833
Weighted average exercise price, ending balance	$ 0.49	$ 0.47
Remaining contractual term, ending balance	1 year 5 months 4 days

Schedule of Stock-based Compens

Schedule of Stock-based Compensation Expenses (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total stock-based compensation	$ 1,013	$ 2,273
Restricted Stock [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total stock-based compensation	296	1,935
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total stock-based compensation	454	279
Warrant [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total stock-based compensation	263	59
Accrued Stock Compensation [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total stock-based compensation

Stock Based Compensation (Detai

Stock Based Compensation (Details Narrative) - Share-Based Payment Arrangement, Option [Member]	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Dividend rate	0%	0%
Share-based payment arrangement, period for recognition	2 years 7 months 6 days
Measurement Input, Expected Dividend Rate [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Dividend rate	0%

Commitments and contingencies (

Commitments and contingencies (Details Narrative)		12 Months Ended
	May 06, 2021 USD ($)	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2022 CAD ($) shares	Sep. 30, 2021 USD ($)	Sep. 30, 2022 CAD ($) $ / shares
Loss Contingencies [Line Items]
Shares issued, value		$ 285,000		$ 2,870,000
Canaccord Genuity Corp [Member]
Loss Contingencies [Line Items]
Sale of stock number of shares issued in transaction | shares		16,926,019	16,926,019
Share price | $ / shares					$ 0.55
Sale of stock consideration received on transaction			$ 10,309,210
Brian Hayek Et Al [Member]
Loss Contingencies [Line Items]
Loss contingency damages sought value	$ 349,876.69
Agency Agreement [Member] | Agent [Member]
Loss Contingencies [Line Items]
Finance fee					$ 100,000
Cash					$ 50,000
Shares issued, value			$ 50,000
Number of shares issued | shares		90,909	90,909
Estimated offering cost			$ 350,000
Warrant [Member] | Canaccord Genuity Corp [Member]
Loss Contingencies [Line Items]
Exercise price | $ / shares					$ 0.68
Maturity date					Apr. 23, 2023
IPO [Member] | Canaccord Genuity Corp [Member]
Loss Contingencies [Line Items]
Shares issued, value		$ 420,000
Number of shares issued | shares		972,092	972,092
Share price | $ / shares		$ 0.43
IPO [Member] | Broker Share [Member]
Loss Contingencies [Line Items]
Additional shares percentage		7%	7%
IPO [Member] | Broker Warrant [Member]
Loss Contingencies [Line Items]
Additional shares percentage		3.50%	3.50%
Exercise price | $ / shares					$ 0.55
Over-Allotment Option [Member] | Canaccord Genuity Corp [Member]
Loss Contingencies [Line Items]
Sale of stock number of shares issued in transaction | shares		1,471,291	1,471,291
Sale of stock consideration received on transaction			$ 809,210.05
Over-Allotment Option [Member] | Agency Agreement [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Additional shares percentage		15%	15%
Sale of stock number of shares issued in transaction | shares		2,590,909	2,590,909
Gross proceeds from issuance initial public offering			$ 10,925,000
Agents commission			764,750
Proceeds from issuance initial public offering			10,160,250
Over-Allotment Option [Member] | Agency Agreement [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Gross proceeds from issuance initial public offering			9,200,000
Agents commission			644,000
Proceeds from issuance initial public offering			$ 8,556,000

Subsequent events (Details Narr

Subsequent events (Details Narrative) - USD ($)		1 Months Ended
	Jan. 02, 2023	Nov. 30, 2022	Jan. 03, 2023	Apr. 30, 2022
Private Placement [Member]
Subsequent Event [Line Items]
Extension fee				$ 5,000
Exercise price, per share				$ 0.07
Subsequent Event [Member] | Oregon Real Estate Agreement [Member]
Subsequent Event [Line Items]
Land purchase price	$ 275,000
Subsequent Event [Member] | Unsecured Promissory Note [Member]
Subsequent Event [Line Items]
purchase of warrants		250,000
Extension fee		$ 5,000
Subsequent Event [Member] | Unsecured Promissory Note [Member] | Private Placement [Member]
Subsequent Event [Line Items]
Debt Conversion, Original Debt, Amount		$ 250,000
Interest rate		10%
Exercise price, per share		$ 0.05
Subsequent Event [Member] | Unsecured Convertible Promissory Note [Member]
Subsequent Event [Line Items]
Debt Conversion, Original Debt, Amount	$ 250,000
purchase of warrants	500,000		7,352,941
Interest rate	12%
Exercise price, per share	$ 0.005
Conversion rate	50%
Convertible Debt	$ 125,000
Conversion per share	$ 0.01